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 ABSTRACT 
 
Cegana vatham is a most commonest degenerative disease now a day. Its 
amplified occurrence in recent times is due to stress, strain and abnormal dietary 
habits. This disease affects the neck and upper extremities with its signs and 
symptoms like that of cervical spondylosis. I had arrived at the diagnosis of the 
disease by using siddha parameters like envagaithervugal, kaalam, Thinai, Mukkutra 
Verupadugal and modern parameters. Appalakara chooranam  is a  siddha mineral 
formulation mentioned in Gunapadam Thathu Jeeva Vaguppu (Part II & III) (Page 
No: 368) which is indicated for vatha diseases.  
 
Therefore I  desired to evaluate the efficacy of “Appalakara chooranam” in 
the treatment of Cegana vatham. For the purpose of standardization. clinical trial 
medicine was subjected to biochemical,anti-microbial and pharmacological 
analysis.Anti- inflammatory, analgesic, anti-ulcer activities were studied under 
pharmacological action.Safety profile of the trial drug was evaluated and no morbidity 
or mortality was noted in experimental animals.  
 
20 OP and 20 IP patients of both sexes were selected and they were 
administered with the trial drug. At the end of the study majority of the cases which 
showed good clinical improvements.All the relevant reports were statistically 
analysed. 
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CHAPTER- I 
INTRODUCTION 
1.1.BACKGROUND 
The modern industrialization imbalance the ecosystem which paves way for 
varied type of diseases. To uproot the disease there should be a system of medicine 
which goes hand in hand with nature. The typical example is Siddha system of 
medicine, which is one among the “AYUSH system. The unique nature of this system 
is its continuation of service to humanity from time immemorial.  
 
The Siddha system of medicine is believed to be originated from Lord Siva 
and transmitted to eighteen Siddhars. The siddha system has been involved by the 
hard work and hearted contribution of Tamil sages called “Siddhars”. Agasthiyar is a 
father of Siddha system of medicine. 
 
Siddhars Classified the diseases as 4448 types .According to Yugi Vaithya 
Chinthamani-800 Cegana Vatham  is coming under the 80 types of Vatha diseases. 
Cegana Vatham  can be correlated in modern aspect as Cervical spondylosis.                                         
 
 The World Health Organization (WHO) estimated that 80% of populations 
were using traditional medicines in developing countries for primary health care 
needs. In that way, Siddha medicine has profound vital role in disease , prevention 
and prophylaxis through its herbal medicine and other form of medicine like 
chendooram, Parpam and other 32 types of preparation. 
 
According to the classical text Noi nadal and noi mudhal nadal part 2 and yugi 
vaidhaya chinthamani800 are clearly mentioned that preclinical symptoms of Cegana 
Vatham (Cervical spondylosis). This is one of the most common degenerative 
disorders of the spine, affecting 95% of patients by the age of 65 years . The non-
inflammatory disc degeneration is one of the defining characteristics of spondylosis. 
The majority of people with spondylosis are asymptomatic. Patients who are 
symptomatic tend to be older than 40 years old and presents 3 types of symptoms; 
neck pain, cervical radiculopathy, and/or cervical myelopathy [World Spinal Column 
Journal, Volume 2 / No: 3 / September 2011] 
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In recent times, pain in the neck is frequently reported from the public, as 80% 
of them are engaged with a profession which makes chronic flexion to the cervical 
vertebrae. 
 
The media must be protected from degeneration, ageing and disease. So the 
siddhars followed specific type of life style and food style which was also included in 
this system. 
 
Applakara choornam is coming under the heading of upa rasangal (120 
varities) topic and it is one of the natural salts. The applakara choornam has taken 
from the classical siddha literatures and also mentoined kaarasaaram tittle or mineral 
formulation (Gunapadam Thathujeeva vaguppu [page:368). Guidelines of WHO and  
AYUSH insisted the guidelines for quality control to better standardization of the 
drugs as pertaining to Pharmacopoeia Laboratory of Indian Medicine(PLIM). The 
literature collections has been proved the individual constituents of the preparation 
possessing Anti inflammatory, analgesic and anti ulcer activities. The Systematic 
steps should be taken to the standardization of traditional drugs by using modern 
technique   like SEM, EDAX, FTIR etc. 
 
The pharmacological research works undergone on the constituents of the trial 
medicines Appalakara chooranam justified its potential effect in the clinical study of 
the management of Cegana Vatham  (Cervical spondylosis). 
 
 
 
 
 
 
 
 
 
 
3 
 
1.2. AIM AND OBJECTIVES 
AIM  
 A prospective open labeled phase-II Non-Randomized clinical study of 
Appalakara chooranam   for Cegana Vatham (Cervical spondylosis). 
 
OBJECTIVES:- 
A. Primary Objective: 
• To clinical evaluation and documentation of   the therapeutic efficacy in 
clinical trial drug in Cegana Vatham . 
 
B. Secondary Objectives: 
• To findout the Anti inflammatory and Analgesic Pharmacological activity of 
Appalakara chooranam. 
• To determine the additional effects and siddha parameters changes in Cegana 
Vatham . 
• To carry out modern parametric changes in Cegana Vatham  (Cervical 
Spondylosis). 
• To determine safety profile of the clinical trial drug. 
• To carry out the bio chemical analysis in Applakara choornam. 
• Study about the prevalence of Cegana Vatham  in relation between diet and 
lifestyle. 
• To adjudge the Anti microbial and Anti ulcer study of the clinical trial drug. 
• To assess contents of chemical compound performed through FTIR, SEM and 
XRD analytic methods. 
• To discuss about prognosis and treatment effect after end of the study.  
 
 
 
 
 
 
 
REVIEW OF LITERATURES
2.1. IN JOURNAL ASPECT
  
I. Karthikeyan karu and vetha merlin 
work of Acute anti inflammatory studied by 
oedema and Chronic inflammotary study was carried out by cotton pellet 
granuloma of a mineral drug 
end of result, he found
inflammotary activites,
 
II. Senthil kumar and Moorthy et
arthritic, herbo mineral preparation 
results was confi
manganese, zinc, 
 
 
 
 
 
 
 
Applakaram (Sodium carbonate)
 
2.2 IN SIDDHA LITERATURE
2.2.1. GUNAPADAM
Tamil name   
Other name   
Chemical name   
Chemical composition 
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CHAPTER - II 
 
--  APPALAKARAM 
kumara. 2012 was done a pharmacological
carageenan induced rat hind paw 
– appalakaram (impure sodium carbonate)
 applakaram was a moderate acute and chronic anti 
 it was better result on osteo arthritis. 
 al.2011 had did a work of Standartation of anti 
by using FTIR-Heavy metal analysis.
rmed the presence of metals, such as iron,
nickel, cobalt, arsenic, cadmium, lead and mercury.
   Applakara Chooranam
 
 
 ASPECT -  APPALAKARAM 
: Appalakaram 
: Ulaman,Uvarman, Savudduppu 
: Sodium carbonate, 
:  Na2 CO3 
 
. At the 
 The 
 copper, 
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Pharmacological Actions  :   Anti inflammatory 
     Analgesic 
     Antispasmodic 
     Antacid 
     Antidote 
     Antiseptic 
                       Alterative 
     Carminative 
     Diuretic    
   
 Nadkarani, 1993 was mentioned in his text book page no.101-10, the 
indications of Applakaram, further he mentioned that  applakaram is antacid,alterative 
and diuretic in actions. The varities of Sodii carbonas impura  (or) sodium carbonate 
is responsible to  cure rheumatism (Antiinflammation ) and kidney disorders.The 
same tobe quoted in gunapadam part II&III ,page no.368.In this text book additionaly 
lithotriptic and anti flatulance actions were added. 
  
2.2.2 GUNAPADAM ASPECT -  APPALAKARA CHOORANAM 
Ingrediants of Appalakara chooranam 
The various Siddha literatures collections are given below 
 
Table No -  I           
Gunapadam Thathu Jeeva Vaguppu :Vol II&III pg no.368 
 
NAME 
PHARMACOLOGICAL          
ACTIONS 
THERAPEUTIC 
USES IN SIDDHA 
 
Appalakaram 
 
 
Antiinflammatory 
Analgesic 
Antispasmodic 
Antacid 
 
 
Vatha diseases 
Gunmam 
Soolai 
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Table No - II 
Patharthaguna Vilakkam  Thathu Jeeva Varkkam:pg no.24 
 
Table No - III 
T.V SAMPASIVAMPILLAI  Pg 1267&1268 
 
 
The above tabe coloumn I & III showed Appalakara Chooranam was a good anti 
inflammatory and analgesic activities were present. So, this action was highly 
responsible to reduced the  Cervical spondylosis pain. 
 
 
                                                 
 
                                                                        
 
NAME 
PHARMACOLOGICAL   
ACTIONS 
THERAPEUTIC USES 
IN SIDDHA 
 
Savudduppu/Appalakaram 
 
Antacid 
Carminative 
Antispasmodic 
 
Dyspepsia 
Flatulence 
Rhumatism 
Diseases of mouth 
 
NAME 
PHARMACOLOGICAL   
ACTIONS 
THERAPEUTIC USES 
IN SIDDHA 
 
Ulaman/  Appalakaram 
 
Antiinflammatory 
Analgesic 
Antiseptic 
Antidote 
 
Vatha diseases 
Thandaka vatham 
Reducing of Metal Toxic 
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2.2.3- IN SIDDHA ASPECT- VATHAM 
 
DEFINITION:- 
The biological function of the human health is governed by three distinct 
humours, It is known as vatham, pitham and Kapham. In a healthy man, these three 
humours are held in 1: ½ : ¼ ratio. When this humours is altered in ratio can caused 
by disease. It was mentioned in thirukural, 
 “lqgqEr<!GjxbqEl<!Ofib<!osb<Bl<!F~Ozii< 
!! utqLkziou{<{qb!&e<X”                                     -      kqVg<Gxt< 
 
The theriyar maruthuva bharatham was mentioned, the first phase of human 
life is attributed in earlier age to vatham, the middle age  to pitham and remaining 
period was  kapham. 
 “uiklib<!hjmk<Khqk<kue<eqbib<!gik<K!
! sqOzk<KlsQklib<!Kjmk<K”       
                                                                                             -   Okjvbi<!lVk<Ku!hivkl< 
SITES OF VATHAM 
The vayu (Air) and Aahayam (space) was combained together to  formed by 
Vatham.It is responsible for all movements of locomotar systems. 
 “oftqf<kqm<muiklhiek<jkh<!hx<xq!
! fqjxf<kqjmjbs<!Osi<k<Kf<kqg<!!gQOpfqe<X!
! Gtqf<kqm<m!&zlKiomPf<Kgilg<!
! ogicbqjmjbh<!hx<xqobPr<!G{k<jkh<!hiOv!
!
! G{lieouZl<jhOlx<oxig<jgfic!
 ....................................................................... 
! fq{lieohiVk<kqmLl<!Ovilg<!giZl<!
! fqjxuigqlir<gqsolz<!!zil<hvf<K!
! /////////////////////////////////////////////////////////////////////////////////////////////////!
! /////////////////////////////////////////////////////////////////////////////////////////////!
! giz<gim<cuikolr<Gr<gzg<Gf<!kiOe”!!!.!juk<kqbskgl<<< <<!
According to Vaithiyasathagam was mentioned in places vatham are,!
* Rectum   * Joints 
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* Umblicus   * Bones 
 * Hibjoint   * Skin 
 * Muscles   * Nervous plexus 
 * Hair follicles  * Anus  
 
In Maruthuva thanipadalkal, Vatham is predominent in Small intestine, Bone, 
Ear, Thigh, Skin, Hip joint. 
‘d{<csjlk<Kmx<!%m<Mr<!Gmx<hGkq!
kq{<cxoze<HosuqGxr<G!.!uq{<m!
okiMU{i<UOkix<Xuqg<Gl<!!OkizqMh<hqu<uiXl<!
uMuqzqmilil<!utqg<G”                      - lVk<Ku!keqhimz<gt<!
 
“nxqf<kqMl<!uik!lmr<Glzk<kqeqz<”;! .!kqV&zi<!
!
“fiole<xuikk<Kg<!gqVh<hqmOlOgtib<!
fihqg<Gg<!gQope<XfuqzziGl<”  .!B,gqLequv<!
!
“osh<HLf<kqsqjkBl<!uikfqjz”   - juk<kqbsivsr<gqvgl< 
!
According to Thirumoolar, Yugimunivar and VaithyaSarasangraham, the 
vatham is take place or dominated in below level the umbilicus. 
NATURAL FUNCTIONS OF VATHAM 
“yPr<Gme<!kiOkp<!&s<Osir<gq!-br<g!
wPs<sqohxwh<h{qBlix<x!.!wPf<kqiqb!
Ougl<!Hze<gTg<GOlus<!SXSXh<H!
uigtqg<Gl<!lif<ki<g<GuiB”!! !
.!lVk<Ku!keqhimz<gt<!!
 Alertness  
 Respiratory movements 
 Mental and physical activities 
 Elimination of the “fourteen physiological reflexes” (vegamgal) 
 Functioning of the “Seven udalkattugal’  
 Strengthening of the five sensory organs (Iymporigal) 
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DERRANGED (or) ALTERED VATHAM 
The Noinadal noimudhal nadal thirattu-part I, page no 158, dearranged vatham can 
produce the following symptoms are, 
 Bodyache 
 Pricking pain 
 Tearing pain 
 Nerve weakness 
 Tremor 
 Rigidity 
 Dryness 
 Movements 
 Weakness 
 Throbbing pain 
 Pain felt as that of traumatic cause 
 Dislocation of joints 
 Weakness of functional organs and loss of functions 
 Constipation  
 Retention of Urine 
 Thirst 
 Paralysis of limbs 
 Severe pain in calf and thigh muscles  
 Pricking pain in the bones 
 All taste to be like astringent 
 The skin, eyes, faeces and the urine are black in colour. 
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QUALITY OF VATHAM 
The qualities and character of vatham is,  
 Hardness  - Kadinam 
 Dryness  - Varatchi 
 Subtility  - lesu 
 Coldness  - Kulirchi 
 Mobility  - Asaithal 
 Minuteness  - Anuthuvam 
 
OPPOSITE REACTIONS OF VATHAM IS, 
Soft   -  Mirudhu 
Unctuous  - Pasumai 
Heaviness  - paluvu 
Hotness  - Akini  
Stability  - Sthiram 
Solid   - Katti 
 
RELATION WITH TASTE  
 The Noi nadal text and agasthiyar nadi is indicated Sour taste, it was increased 
vatham. 
 
“Osk<Kl!olPf<kqVg<gqx<!kqk<kqh<H!fiuqOzXl<!
Wk<kqb!gsh<HlQxqz<!wPl<hqMl<!hqk<kliGl<!
lik<kqb!Htqh<H!lQxqz<!uf<kqMl<!uikliGl<!
Osk<Klf<!k{<{Qi<!hqk<kk<!kQgix<XuikliOl”! .!ngk<kqbi<!fic!
! ! Ofib<!fimz< higl< I, hg<g!w{< 22 
  
Aggravating factors 
The Sour and Astringent tastes aggravates the Vatham. According to Noinadal 
part.I book is mentioned in same lines. 
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“HtqKui<uqR<!Sr<gxqbix<!H,iqg<Gl<!uikl<?!
ytqBui<jgh<!Ohxqz<!hqk<Ks<!sQXl<!.!gqtqolipqOb!
gii<h<hqeqh<HuqR<sqx<!ghl<!uqR<SR<!sm<cvks<!!
Osvh<H{i<!Ofib[giOk#!! ! .!Ofib<!fimz< higl< I, hg<g!w{< 23!
 
Neutralising taste 
According to kannusamiyam, Sweet, Sour and Salt taste will neutralize the 
increased vatham. 
 
“uikOlzqm<miz<!lKvl<!HtqBh<H!
OskLxs<!osb<BR<!sqjxbl<!.!ykg<Ogt<!
givf<!Kui<gsh<Hg<!gim<MR<!Sjuobz<zil<!
sivh<!hiqgivR<!six<X”   - !g{<[silqbl< 
Ofib<!fimz< higl< I, hg<g!w{< 24 
 
RELATION WITH ELEMENTS (Pancha Pootha Theory)  
The combaination of air and space forms  vatham;  and fire alone  formes the 
pitham and kapham is formed by combaination of water with earth. 
           
Vatham -           Air + space 
Pitham  - Fire 
Kapham - Water + Earth 
 
The combained two boothams  forms one taste and constituent boothams as 
follows. 
TASTE BOOTHAMS 
Sweet Earth + Water 
Sour Earth + Fire 
Salt Water + Fire 
Bitter Air + Space 
Pungent Air + Fire 
Astringent Earth + Air 
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Alteration in Vatham 
Vatham gunam is developing in Aadi, Avani, purattasi and Iyppasi tamil 
months.So, Vatha disease is mainly dominated in above months and Kadagam to 
Thulam rasi also inceases in above months.  
  
The type of alteration of vatham are : 
1. ThannilaiValarchi :-!)ke<eqjz!uti<s<sq* 
 
Definition 
The three humours are provoked in their own location it is called as 
“ThannilaiValarchi. It is called “SanthiSamayam” 
 
Limitation 
Hatefulness of the things which are causing aggravation and attraction to 
things having opposite quatation. 
 
Duration 
Vatham is aggravated in MudhuvenilKalam (Aani and Aadi). 
 
2. Vetrunilai Valarchi :- )Oux<Xfqjz!uti<s<sq) (Displacement of aggravation) 
Definition 
The Provoked humoursis displaced from their own location and aggravated in 
vetrunilaivalarchi. It is called as PrakobaSamayam. 
 
Limitation 
Signs and symptoms of the affected humours and the pathological conditions 
of the udalthathukkalgives the details of the limitations. 
 
Duration 
Vatham attains displacement of aggravation in “Kaarkalam (Aavani and 
Purattasi) 
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3. ThannilaiAdaidhal )ke<eqjz!njmkz<) 
Definition 
Provoked humours, which is neutralizing in its own character is called 
ThannilaiAdaidhal. It is called as SamanaSamayam. 
 
Duration 
The provoked vatham neutralizes during koodhirkalam (Iyppasi and Karthigai) 
 
FACTORS WHICH ALTER VATHAM 
“uiBuqe<!G{k<Kme<!$m[gqz<!
! ! uiBuqeqmr<gtqz<!Ofib<gT{<M!
uiBuqz<!Gtqi<s<sqkie<!%ccOzi!
! ! uf<kqMl<!fzqgTl<!Ouxqmk<Ok!
uiBuqz<!nez<kVl<!ofb<h<hjlf<kiz<!
! ! uiBUl<!nmr<gqMl<!uib<jlbqK!
uiBuqe<!hq{qgjth<!Ohig<gqmOu!
! ! uGk<kqMl<!Leqolipqg{<cMOl”                lVk<Ku!keqh<!himz<gt<!
 
 When hot foods are mixed with vathamvatham gets “ThannilaiValarchi” 
 When cold is mixed with vatham, “Vatham” gets “VetrunilaiValarchi” 
 And when only foods with hotness are mixed with vatham, “Vatham neutralizes in 
its own property” that means healthy conditions. 
! ! ! ! !  
CHARACTERISTICS OF VATHATHEGI 
 According to Pathinenn Siddhar Nadi Sasthiram, Vatha thegi body has in 
black or red in colour, rough and thickened skin, increased sexual activity, 
spermathorrea, body pain, loss of appetite and flatulence.  
  “g{<miObiuikk<kiozPf<kOkgl<!
! ! gm<cjlbib<k<!kck<kqVg<gr<!gVjlosl<jl!
u{<miGr<!Gpzit<!Olzx<!huijs!
! ! uib<UlqGl<!OhigLXleR<sqg<!oge<xu<!
d{<miOznx<hU{cwiqh<OhiM{<[!
! ! LXkiXGjxs<sZml<Hgjtdsqkl<”.!
! ! ! ! ! .!hkqo{e<!sqk<ki<!ficsi^<kQvl<!
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According to Siddha Maruthuvanga Surukkam  
 
Vathathegi has an appearance of 
 Thin, tail built 
 Bulky thigh 
 Thick eye brows 
 Cool sight 
 Black and white mixed coloured skin complexion. 
 Dark and fissured hair in scalp. 
 Clear speech, sometimes slurring  
 They have a desire of sweet, sour, salt and hot food stuff. 
 Dislike in cold things. 
 Over eating. 
 Less strength. 
 Less Sexual desire 
 Impotency 
 Predictable games, music, exercise, massage, hunting 
 Theft 
 Short interrupted sleep. 
 Slumber with half closed eyes. 
 Seeing the sky, mountain and forest in night dreams. 
 
Features of increased vatham 
 Body will become black and emaciation. 
 Liking to eat hot foods. 
 Tremor  
 Distended abdomen  
 Constipation 
 Weakness 
 Disturbance in sleep 
 Diminished activities of the five sense organs. 
 Slurring speech 
 Vertigo 
 Loss of perseverance 
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Features of Decreased Vatham 
 Body Pain 
 Low Voice 
 Decreased physical  activities 
  Mental agony 
 Syncope 
 
MUKKUTRA VERUPAADUGAL 
By any one or other etiological factors vatham is vitiated first.  Then it affects 
the other dhosamspitham and Kapham which are in three dhosa equilibrium.Then the 
ten vayus, seven udalkatugal and other structures are also affected according to the 
severity of the illness. 
 
In generally vatha diseases, Abanan, viyanan, samanan, Devathathan are 
affected. The Saram, Seneer, OOn, Kozhuppu and Enbu are affected in one by one. 
 
Naadinadai 
In vatha disease, the following naadi are showed in general. 
1. Exaggeration of vathanaadi 
2. Vathapitha thondhanaadi 
3. Vathakabha thondhanaadi 
4. Kabhavatha thondhanaadi 
5. Kabhapitha thondhanaadi 
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2.3. SIDDHA ASPECT - CEGANA VATHAM 
 
2.3.1. IYAL  (DEFINITION) 
 Cegana Vatham  is one among the 80 types of vatha disease which it was 
described by Yugi vaithya chinthamani 800. It is defined as a kind of neurologic pain 
affecting the neck and extending into the upper limb. It is attended with heaviness of 
body, giddiness, burning sensation of the eyes and dysuria. 
    T.V. Sambasivam pillai Dictionary 
 
2.3.2. NOI VARUM VAZHI (ETIOLOGY ) 
Yugi has not mentioned specific symptoms of Cegana Vatham .  He was 
summarised the causative factors for vatha disease. Yugi munivar mentioned  various 
factors for the cause of vatha diseases, and includes various intrinsic and extrinsic 
factors can produce the vatha disease i.e Cegana Vatham . The various intrinsic and 
extrinsic factors are, 
 
I.  According to the yugi Vaithya chinthamani 
 “we<eOu!uikl<ki!oe{<h!kiGl<!
! ! -gk<kqOz!leqki<gTg<!ogb<B!liX!
! hqe<eOu!oh{<kjeOb!OsivR<!osb<K!
! ! ohiqObii<gt<!hqvil{jvk<!Ki]{qk<Kl<!
! ue<eOu!us<osik<kqx<!OsivR<!osb<K!
! ! likihqki!GVju!lxf<k!Ohi<g<Gl<!
! ge<eOu!Oukk<jk!fqf<jk!osb<kiz<!
! ! gibk<kqx<!gzf<kqMOl!uikf<!kiOe”!
.!B,gq!juk<kqb!sqf<kil{q!)!himz<!w{<!354*?!hg<gl</!:3!
 
The yugimuni in chinthamani is noticed,the vatha disease can produced the 
following reasons are, Breach of trust, abusing the rituatists, exploiting the properties 
of charities, ingratitude toward mother, father and teacher and abusing holy 
suripisre.Intake of food with bitter, astringent,pungent taste, drinks, daysleep, 
insomnia, starvation, sexual desire also produced the vatha disease. 
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“kioee<x!gsh<OhiM!Kui<h<H!jxh<H!
sikglib<!lqR<SgqZr<!sjlk<k!u{<{l<!
Noee<x!uixqeK!ohisqk<k!ziZl<!
Ngibk<!OkxzK!Gck<k!ziZl<!
hioee<x!hgZxg<g!lqvi!uqpqh<H!
hm<ceqOb!lqgUXkz<!hiv!olb<kz<!
Okoee<x!olipqbii<Olx<sqf<!jkbikz<!
sQg<gqvlib<!uiklK!oseqg<Gf<!kiOe”!
.!B,gq!juk<kqb!sqf<kil{q!!hi/w{<!355?!hg<gl<!:3!
 
In Agasthiyar Gunavagadam, the following reasons are produced the vatha 
disease. 
Vatha disease caused by: 
 Brain disease 
 Renal  disorders 
 Sexually transmitted disease 
 Spino-vertebral disease   
 Menorrhagia 
 Toxic organic and inorganic substances  
 
“okiz<jz!osb<b!-e<El<!ouG!uikOfib<gt!
okiz<Zzgqz<!lif<kVg<Gg<!gi{<hK{<M!
wz<jzbqz<jz!uikOfib<!Ofi<jl!ke<je!
-bz<hig!nxqf<kqmOu!uqhvr<!OgOt” 
 
“uquvlmi!nskqse<eq!&jt!OfiU!
uqiquie!&jtbK!lqVKuigq!
-ueqkeqz<!kqmligh<!OhiukiZl<!
nh<hOe!&k<kqvg<!G{<cg<gib<!uqbikqbiZl<!
kuLequi<!kQi<gig<jg!OlgOvigl<!
ke<jlBt<t!Lk<k{<Mg<!ogic!uqbikq!!
nulqzih<!hiqs!fvl<hPk<kr<!g{<mib<!
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!! ! n[Glmi!uikOfib<!NMl<hiOv” 
“n[Glmi!lilqsk<kqe<!uqbikqbiZl<!
nh<hOe!$kgk<kqe<!ohVg<gziZl<!
G{lqz<zi!-vsl<!ur<gl<!kqe<eziZl<!
GcogMk<k!uiklK!d{<milh<hi” 
.!ngk<kqbi<!G{uigml< (hg<g!w{<;!653) 
!
According to Sabapathy   Kaiyedu:- 
Diet which provoked vatha, curd, irregular food and in appropriate diet, cold 
exposure, increased sexual desire can cause vatha disease. 
 
“uiiqkV!gib<gqpr<G!ujvuqzi!kbqzz<!Ogijp 
Leqkbqi<!Ohie<lqMg<G!Ljxbqzi!U{U!Ogimz<!
Gtqi<kV!utqbqx<Oxgr<!Geqh<Hx!uqzuz<!oh{<ci<!
gtqkV!Lbg<gl<!ohx<Oxii<!gcosbz<!gVuqbiliz;”!
! ! ! ! ! ! ! ! .!shihkq!jgObM!
 
According to Theraiyar vahadam 
High exposure in sunlight, polyphagia, frequently sexual contact, untime food 
intake can caused by vatha disease. 
 
“oub<bqzqz<!fmg<jgbiZl<!lqgk<!k{<{Qi<!Gcg<jg!biZl<!
osb<bqjp!lgtqeijts<!Osi<f<kE!huqg<jgbiZl<!
jhbOu!d{<jgbiZl<!higx<gib<!kqe<jg!biZl<!
jkbOz!uikOvigR<!seqg<Gole<!xxqf<K!ogit<Ot” 
! ! ! .!Okjvbi<!uigml<!(hg<g!w{<:78)!
  
According to pararasa sekaram - vatha roga nithanam 
“okipqz<ohX!jgh<Hg<givf<!fz<Kui<k<kz<!uqR<SgqZR<!OsiXl<!
hjpbkil<!uvG!lx<jxh<!jhf<kqje!bVf<kqeiZl<!
! wpqz<ohx!hgZxr<gq!-vuqeqZxr<gi!kiZl<!!
ljpfqgi<!GpzqeiOt!uikr<Ogi!hqg<Gr<!giO{”!
! !
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“gi{Ou!lqgU{<miZr<!gVKhm<!cequqm<miZl<!
lieje!bii<g{<!Olig!lxg<gqE!lqGk<kqm<miZl<!
N{u!lzr<gml<jl!br<rOe!uqmik!kiZl<!
uiEke<!lmfz<!ziOt!uikr<Ogi!hqg<Gr<!giO{”!
! ! ! ! .!hvvisOsgvl<!uikOvig!fqkiel<!
!
According to pararaja sekaram –vatha roga nithanam , excessive  intake  of 
bitter, astringent, pungent taste, foods contained  previous day rice, ragi, day time 
sleep, insomnia, over eating, starvation,  over  sexual activity, anger and anxiety can 
produce vatha disease.!
 
According to thirukural 
 The three vital humours which increase or decrease caused by vatha disease. 
 “lqgqEr<!GjxbqEl<!Ofib<!osb<Bl<!F~Ozii< 
utq!Lkzi!ou{<{qb!&e<X”! !!!!!!!! .!kqVg<Gxt<!
!  
According to Agasthiyar kanma kaandam - 300 
 “F~oze<x!uikl<!uf<kujg!kiO{K!
!!!!!! K{<jlbib<!ge<lk<kqe<!ujgjbg<!OgT!
gizqOz!Okie<xqbK!gMh<hOkK!
!!!! ! jggizqz<!Lmg<gqbK!uQg<gOlK!
OgizqOz!hMgqe<x!uqVm<s!lie!
Gpf<jk!lvf<ke<je!oum<mz<Olz<!Okiz<sQuz<!
fizqOz!sQuosf<K!giz<Lxqk<kz<!
fz<z!ogi{<H!kjp!Lxqk<kz<!fzqk<kz<!kiOe”!
.!ngk<kqbi<!ge<lgi{<ml<!)himz<!67*!
 
• Cutting the trees 
• Breaking the legs of living animals 
• Cutting the branches and leaves of living 
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According to Manmurukkyam 
High intake of cold,  excessive oily foods, excessive sexual activity, insomnia, 
drinking contaminated  water, stress, blood loss, anger, depression, weight loss, 
prolonged illness,  genital ulcer, starvation, deficiency of hormones,  nerve plexus 
injury, bone degeneration and toxic medicines  may caused by  vatha disease.It was 
mentioned in man murukiyam text book. 
 
“Gtqi<s<sqBl<!ofib<jlBl<!Ljmbe!U{<{z<!
H{i<s<sq!lqGk<kz<!dxg<gl<!fQg<gz<!
liSl<!fQVl<!Ng!hMkz<!
kir<gi!Lbx<sqgt<!kjgbxs<!osb<kz<!
GVkq!Gjxkz<!fqjeU!lqGkz<!
Kbi<!sqel<!Lkzqb!lqGh<hmz<!
ucb!Lkz!olzqf<K!Ohikz<!!
gMl<!!hq{qBXkz<!ngm!olzqkz<!
dt<TXh<hqx<!sqz!fQr<gz<!uQp<kz<!!
gVuibqx<!H{<hmz<!dmz<!FXr<gqMkz<!
dbqi<fqjz!kig<gz<!d{<{i!kqVk<kz<!
dml<hqz<!hiz<gt<!lqgg<!Gjxf<kqMkz<!
d{i<s<sq!fqjzgt<!dxk<!kig<gqMkz<!
we<H!sqjkkz<!fR<S!lVf<K{<{z<!
we<hUl<!hqxUl<!utqb!Ofib<gm<!
gch<hjmbig!nxqkz<!fzOl”! ! ! ! !
! ! ! ! ! .!lie<!LVg<gqbl<!
 
2.3.3 POTHU KURIGUNAM (CLINICAL FEATURES) 
According to Yugi vaithya chinthamani the clinical features of  Cegana 
Vatham was clearly explained, 
 
“OgTOl!gPk<kqe<!gQpjvg<G!OlZl<!
ogcbie!gvlqv{<M!lqgOu!ofif<K!
uiTOl!siQvolz<zir<!gek<kq!Vg<Gl<!
uizqhi<g<G!ler<g{<[!lbg<gliGl<!
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!
WTOl!bqv{<M!g{<[!oliqs<s!Z{<mil<!
Wx<xlib<!lzf<kiE!lqXgqg<!gi[l<!
OkTOl!ogim<ceK!Ohix<gMg<Gl<!
osge!uikk<kqeqm!kQi<g<gf<!kiOe”!
.!B,gq!juk<kqb!sqf<kil{q!911!
!!!!!!!!himz<!w{</391?!hg<gl<!w{</218!
 
Clinical Features are: 
1. Neck pain 
2. Radiating pain in the upper limbs 
3. Heaviness of the body 
4. Giddiness 
5. Constipation 
6. Pain like scorpion sting 
7. Tingling sensation and numbness of the upper limbs 
8. Burning sensation of the eyes. 
 
According to  pararasasekaram,!  
“g{<mOkii<!sge!uikr<!gPk<kqe<!gQpjvg<G!OlZl<!
lq{<mzr<!gvlqv{<M!lqgofif<K!g{k<kqVg<Gl<!
l{<cOb!kqlqi<k<Kg<!!Gk<Kl<!uzq!lqgk<KjtU{<miGl<!
u{<mli<!GpzqeiOt!lkqbqeiZe<E!uiOb”.!
.!hvvisOsgvl<!
 
• Pain in the neck 
• Radiating pain in the upper limbs 
• Tingling sensation in the upper limbs. 
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2.3.4.MUKKUTRA VERUPAADUGAL: (PATHOGENESIS) 
According to siddha aspect  
First Degree Derangement: 
 
 
 
 
 
 
  
 
 
  
 
 
 
Second degree derrangement: 
 
 
 
 
 
 
 
 
 
 
 
 
  
Vatha- Vetrunilai valarchi 
Vatha- Thannilai valarchi 
Abanan Viyanan Devathathan 
Constipation Mental depression 1.Heaviness of body 
2.Cruciating pain 
along upper limb. 
3.Pain in Cervical 
dorsal Spine 
Kapham Pitham 
Tharpagam-
Burning sensation 
of eyes 
Sathagam-Giddiness 
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“uiklziK!Oleq!ogmiK” 
!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!!
According to theraiyar, the primary factor which affects first is vatham, which 
is accompanied by the vitiation of pitham and kapham. The factors which affect the 
vatha humour are irregular food habits, physical activities and alternations in the 
atmospheric temperature according to the severity of illness. Ten vayus, seven udal 
kattugal and other structure are also affected. 
 
Vatham 
In Cegana Vatham  are mostly affected in Abanan, Viyanan vayus. Both vayus 
are produced neck pain, pain radiating pain towards to the upper limbs, restricted 
movements in the neck. Samanan and devathathan are also affected. 
 
Pitham  
In Cegana Vatham, Pitham mostly affected in sathaga pitham.  It cans 
produces difficulty in performing regular works because neck pain and pain radiating 
towards the upper-limbs. 
 
Kapham 
In Cegana Vatham patients have , santhigam and Tharpagam ar affected, it can 
produce the pain and stiffness neck and difficult in movements.  
 
Seven udal thathugal 
In Cegana Vatham , saram was affected and cause tiredness of body. Senneer 
affected, which leads to anemia. Oon and kozhuppu was affected in cegana vatham 
patients, it can produce weekness of bone and sclerotic changes and intervertebral 
disc degeneration in the cervical vertebrae. 
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2.3.5.PINIYARIMURAIMAI (DIAGNOSIS) 
The methods of diagnosis in siddha is, 
1.  Poriyal Aridhal   (Inspection)  
2.  Pulangalal aridhal  (Palpation)  
3. Vinadhal   (Interrogation)  
4. Envagai Thervugal  
 
Some other parameters used to confirm the diagnosis.  They are,  
1. Mukkutrangal  (Three humors) 
2. Udalkattugal   (Seven body structures)  
3. Udal vanmai  (body strength)  
4. Thinai   (land and place)  
5. Kaalam   (Season)  
 
1. Poriyal Aridhal (Sensory Organs) 
PORIGAL(SENSORY ORGANS) 
Mei  Skin 
Vai Tongue 
Kan Eye   
Mooku Nose 
Sevi Ear   
 
2. Pulangalal aridhal 
  PULANGAL (SENSATION) 
 Ooru  Touch 
 Osai  Sound 
 Suvai  Taste 
 Oli  Vision 
 Natram  Smell 
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The Cegana Vatham , neck pain, pain radiating towards upper limbs, 
numbness and stiffness of neck, because  Ooru is affected. 
 
KANMENTHIRIYANGAL (MOTOR ORGANS) 
 Kai  - Movements of the  hands  
 Kal  - for walking 
 Vai  - for speaking 
 Eruvai  - for defecation  
 Karuvai - for reproduction 
In Cegana Vatham patients, eruvai, kai has affected.  
 
3. Vinadhal (Interrogation) 
The questions form the patients name, age, sex, occupation, history, residence, 
family history, socio-economic status, diet, habits, complaints of the illness, past 
history, treatment history have been recorded before starting the treatment. 
 
4. Envagai thervugal 
The unique diagnostic principle in siddha system of medicine is ‘Envagai 
Thervugal. Siddhars describe in many of their literatures that “Envagai Thervugal in 
an instrument for a siddha physician to examine and diagnose a patient. 
 
“fich<!hiqsl<!fi!fqxl<!olipq!uqpq!
lzl<!&k<kqv!lqju!lVk<Ku!viBkl<”   - Okjvbi<!
! ! ! ! ! ! ! !  
“olb<g<Gxq!fqxk<okitq!uqpqfiuqVlzl<!jgg<Gxq” - Okjvbi< 
 
According to gunavagada Nadi, 
“kv{qBt<t!uqbikqke<je!bm<mir<!gk<kiz<!
kiexqb!Ou{<MuK!ObOki!oue<eqz<!
kqv{qb!Okii<!ficg{<gt<!sk<kk<!OkiM!
! ! Okgk<kqeK!hiqsl<!uV{l<!fig<G!
-v{lz!&k<kqv!li!lqjug!otm<Ml<!
-kl<!hmOu!kie<hii<k<Kg<!Gxqh<Hr<!g{<M”  
.!G{uigm!fic!)hg<g!w{<;247*!
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According to Thanvanthiri Vaithiyam,!
 “kqVljx!Leque<!%Xl<!uigms<!osb<jg!ke<eqz<!
! uVhz!uqbikq!bie!ujgbxq!GuOk!oke<eqz<!
! dVUX!ficbiZ!oli{<Lg!lzfQviZl<!
! okiquqpq!fiuq!eiZf<!kf<kzf<!g{k<kq!eiZl;” 
.!ke<uf<kqiq!juk<kqbl< (hg<g!w{<:278). 
 
 Nadi  - Pulse 
 Sparisam - Palpation 
 Naa  - Tongue 
 Niram  - Colour 
 Mozhi  - Speech 
 Vizhi  - Eyes 
 Malam  - Faeces 
 Moothiram - Urine 
  
Among Envagai Thervugal, the chief parameter for diagnosis is “pulse 
reading”. The siddha physician’s fingers resemble a stethoscope.Pulse can be felt at 
one inch below the wrist on the radial artery by palpating it with the physician’s tip of 
index, Middle and ring fingers corresponding Vatham, Pitham, Kapham 
respectively.The normal ratio of 1: ½: ¼ Vatham: Pitham: Kapham. This ratio is 
altered can caused by disease. Nadi may be studied at ten places in the body which are 
heel, genital organs, abdomen, chest, ear, nose, neck, hand,  temporal and  vertex.The 
three vital humours are formed by the following combinations are, 
 
!
!
 
 
 
 
 
 
NADI VAYU HUMOURS 
Edakalai Abanan Vatham 
Pinkalai Pranan Pitham 
Suzhumunai Samanan Kapham 
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In cases of vatha diseases the following stages of Naadi nadai are seen 
a.  Vatha Naadi  
“uikolEl<!ficbK!Okie<xqz<!
sQklf<koliM!ubqX!ohiVlz<!kqvm<sq!uib<U!
! sQk!LXr<!gqvi{q!lOgikvl<!fQvijl!
! kqvt<uib<U!$jz!uzqgMh<Hk<!kQjv”   - skgfic!! 
 
According to sadhaga nadi, incresead vathan can cause by diarrohea, 
dysentery, flautulance, ascieties and neuritic pain. The kaviya nadi described in vatha 
disease was mainly produced painful joints.fatiquness and painful joints are present in 
vatha diseases, it was quoated to agasthier. 
! ! ! ! ! ! ! ! ! !
“gi{h<hi!uik!lQxqz<!giz<jggt<!ohiVf<kq!OfiGl<”!
.!giuqb!fic!
“osiz<zOu!uiklK!lQxqx<!xieiz<?!
Osii<ujmf<K!uiBuqeiz<!Okg!olr<Gl<!
olz<zOu!jggiz<g!tskq!B{<mil<!
olb<Lmr<Gl<!fqlqvoui{<{i!kqlq'e<miGl<”!
- ngk<kqbi<!
b. Vatha pitha Nadi 
“ohiVtie!uikk<kqz<!hqk<kR<!Osi<f<K!
……………………………… 
…………………………..………!
gVuie!Okglkq!Zjts<sz<!Osil<hz<!
jggiz<!kxqh<H!fig<!gsg<G!le<el;”.  ! ! !
! ! ! ! ! ! ! ! ! .!skg!fic!
 
“kqVk<klil<!uikk<OkiOm!kQr<ogiM!hqk<kR<!Osiqx<!
ohiVk<Kgt<!OkiXl<!ofif<K!OhikOu!hqcg<Gl<”.!
! ! ! ! ! ! ! ! ! .!Ofibqe<!sivl</!
 
 According to above poem Sadhaga nadi and Noin saram book  mentioned,  the 
increased vatham pitham  can produce the painful joints and neuritic pain. 
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!
c. Vatha Kapha Naadi 
 “hir<gie!uikk<kqz<!Osk<Kl!fich<!
! hiqsqk<kiz<!kqlqi<OlU!Ljxs<s!ziGl<!
kQr<gie!-VlZme<!sf<kq!Okiml;”!! ! ! ! !
! ! ! ! ! ! ! ! ! .!skg!fic!
! !
“uikk<kqz<!Osk<Klligqz<!uzqObiM!uQg<g!L{<mil<”!
! ! ! ! ! ! ! ! ! .!ngk<kqbi<!fic!
 
d. Pitha Vatha Naadi!
! “hqk<kk<kqz<!uikligqz<!hqmiqBr<!giZr<!jgBr<!
! Gk<kK!OhiOzbiGr<!GXkqolb<!hkXl<!hqe<Oe”!
! ! ! ! ! ! ! ! ! .!ngk<kqbi<!fic!
e. Pitha Kapha Naadi 
 “hqk<kk<kqz<!Osk<Klligqz<!hqkx<Xl<!uib<!GtX!lqg<g!
! …………………………………… 
 …………………..……………… 
hqk<kL!olMk<Kg<!ogim<ch<!hqmiqbqz<!Ofiu!kiOl”.!
! ! ! ! ! ! ! ! .!ngk<kqbi<!fic!
 
f.  Kapha Vatha Naadi!
“g{<miObi!sqOzx<hek<kqz<!uik!fic!
…………..…………………………… 
….……………………………………. 
dXkqvm<js!uib<Uuzq!sf<kq!Okiml;”!
! ! ! ! ! ! ! ! .!skg!fic!
  
The following books were clearly noticed that increased  vatha kabham, pitha 
vadha nadi, pitha kabha nadi and kabha vatha nadis are mainly  affected in this 
disease. 
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2. Sparisam 
The temperature of the skin, smoothness and roughness, sweat, dryness, hard 
patches, swelling, abnormal growth, tenderness and nourishment can be felt. 
 
In Cegana Vatham  there was pain and  tenderness in the cervical region and 
generaly body was slight warmth, swelling may be present in the neck and 
extremities. 
 
3. Naa 
The yugi munivar in yugi vaithiya chinthamani book, tongue is blackish in  
colour,  and fissure in tongue are predominantly  noted. 
“gVkqOb!uikOvi!gqg<G!fig<G!
! gXk<kqVg<G!Lt<TOhizou!ck<kqVg<Gl;”!
! ! ! ! ! .!B,gqjuk<kqb!sqf<kil{q!911!
!!!hi/w{</!246?!hg<g!w{</!61!
 
4. Niram (Colour) 
Palor, cyanosis, yellowish and other discolouration of the skin should be 
noted. The type of body is confirmed by the skin colour whether in black (Vatha), red 
or yellow (pitha), white (Kaba) and mixed colours (mixed humours). 
        [Noinadal part I and II] 
  
5. Mozhi (Speech) 
In ceganavatham patients have high  or low pitched voice, slurred speech or 
aphasia,  or dysarthria and  hoarseness of voice can be observed from this study.In 
Cegana Vatham  speech may be varying according to changes in the three humours. 
[Noinadal part I and II] 
 
6. Vizhi (Eye) 
 In Cegana Vatham patients  vizhi was not affected.  
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7. Malam (Faeces) 
Nature, quality, colour, odour, froth and abnormal consistency, constipation, 
diarrhoea, presence of blood mucus, pus, undigested matter, tenesmus can  be noted. 
In pulipani mentioned all the  Cegana Vatham  patients  faeces is black or normal in 
colour and constipation is mainly  present. 
! ! ! !
“‘lzlK!gm<c!Lm<c!bibqMl<!uikk<kqx<G”!
! ! ! ! ! ! ! .!Hzqh<hi{q/!
!
8.  Moothiram (Urine) 
According to theran neerkuri and nei kuri nool, the urine examination  is 
classified into two main  types. They are, 
 a. Neer Kuri     - Physical examination of urine. 
 b. Nei Kuri       - Oil examination. 
                               
  “nVf<KlixqvkLl<!nuqOviklkib<!
ngz<!nzi<kz<!ngizU,e<!kuqi<f<kpx<!
! Gx<xt!uVf<kq!dxr<gq!jugjx!!
! Ncg<gzsk<!kiuqOb!giK!ohb<!
! okiV!L%i<k<kg<!gjzg<Gm<hM!fQiqe<!
! fqxg<Gxq!ofb<Gxq!fqVlqk<kz<!gmOe”!
! ! ! ! ! ! ! .!Okve<!fQi<Gxq!ofb<GxqF~z<!
Neerkuri 
The urine analysis is carried in used  five parameters,namely 
 “uf<k!fQi<g<giq!wjm!l{l<!Fjv!wR<soze<!
! jxf<kqbZtuju!bexGK!LjxOb”!
! ! ! ! ! ! ! .!Okve<!fQi<Gxq!ofb<GxqF~z<!
Niram  - It indicates the Colour of urine 
Manam - It indicates the smell of urine 
Eadai  - It indicates specific gravity of Urine  
Nurai  - It indicates frothy of urine 
Enjal  - It indicates quantity of Urine 
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In addition to frequency, urgency, hesitancy of micturation, painful burning 
micturation sedimentation and any associated discharges can be analysed. In Vatha 
disease dysuria and hesidency of urination can be noted. 
 
Neikuri 
  “fqxg<Gxqg<!Gjvk<k!fqVli{!fQiqx<!
sqxg<g!ou{<o{b<Obii<!sqXKtq!fMuqMk<!
! oke<Xxk<!kqxf<okizq!Wgikjlk<kkq!
 eqe<xkqujz!Ohil<!ofxquqpqbxqUl<!
! ose<xK!HgZR<!osb<kqjb!B{Ov.”!
  
If the drop of oil,the following appearance can observed. 
 lengthens like a snake it indicates vatha disease 
 spreads like a ring it indicates pitha disease 
 Appears like a pearl, it indicates kapha disease 
 
UYIR THATHUKKAL (Three humours) 
VATHAM 
 
Ljxbil<!hqvi{Oei!mhiee<!uqbiee<!
! ! &i<g<gli!LkieoeiM!slie!eige<!
! kqxjlbir<!%i<loeiM!kqiqk!ve<xie<!
! ! Okukk<k!OeiMkeR<!sbEliGl;” 
! ! ! ! ! ! ! !!!.!B,gq!juk<kqb!sqf<kil{q!
hi/w{</49?!hg<g!w{</26!
 
Vatham is classified into ten types. Motor and sensory activities are counted  
by vatham. Types of vathams are,!
 Pranan 
 Abanan 
 Viyanan 
 Udhanan 
 Samanan 
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 Nagan 
 Koorman 
 Kirukaran 
 Devathathan 
 Dhananjeyan 
  !
1. Piranan 
 “hzhzuil<!ohisqh<ohz<ziR<!sQv{l!kig<Gl<!
! Le<e!fipqjgg<G!Lf<F~x<xXhK!Suisl;” 
! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</4:?!h/w{</26!
 
Piranan regulates the respiratory system and digestive system. It is other wise 
termed as ‘Uyirkkaal”. 
 
2. Abanan 
“lVg<gOu!gQp<Ofig<gq!lzl<fQi<!kt<Tl<!
! ! uigig!fqxf<kiEl<!hs<js!biGl<!
! nVg<gOu!Nsek<jks<!SVg<gq!jug<Gl<!
! ! ne<esivk<!jkobz<zil<!Osvjug<Gl;” 
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</52?!h/w{</!27!
  
The function of abanan is to control excretion of stools, sweating, micturation,  
ejaculation of sperms, menstruation and parturition.  
 
3. Udhanan 
“H,lie!le<esivl<!ke<jek<kie<!
ohiVf<kOu!slQhqk<K!fqXk<kq!jug<Gl<!
gilei!obMh<hqk<Kg<!gzg<gq!juk<Kl<!
gzg<gqOb!uGk<Kjug<Gl<!uth<hliGl;”!
! ! ! ! ! ! .!B,gq!juk<kqb!sqf<ki!l{q!911!
!! ! ! ! ! ! hi/w{</54?!h/w{</!27!
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The udhanan duty is to control the breathing and speech. It is also responsible 
for the reflex actions like vomiting, hiccough, cough and digestion. 
 
4. Viyanan 
sqxh<hie!uqbieeK!Okitqz<!fqe<X!
kqgopPhk<!kQvibqv!ficbqZr<!ose<X!
kXh<hie!svusvf<!keqOz!fqe<X!
kieQm<mz<!Lmg<gz<!h{<{q!hiqsr<gtxqBl<!!
.!B,gq!juk<kqb!sqf<kil{q/!
hi/!w{</53?!h/w{</!27!
 
The viyanan is mainly helped in regulate the circulation of various parts of the 
body. It makes both the movable and immovable parts in the body of function make 
them to stretch and flex. It is otherwise termed as paravukaal. 
 
5. Samanan 
“uiole<x!uib<Ugjt!lqR<souim<milz<!
lmg<gqOb!sle<osb<K!lVuh<!h{<[l<!
kiole<x!uXSjujmbk<!k{<{Q!ve<el<!
sle<!osb<K!siQvolz<zil<!sivh<!h{<[l;”!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</55?!h/w{</28!
 
Samanan balancing other types of vayus, six taste, water and food are equally 
distribution all over body.  
 
6. Nagan  
okb<uli!figeqm!sqxh<jhg<!Ogtib<!
! ! osbzie!sgzgjz!big<gq!juk<K!
! jhulib<h<!hic!jug<Gl<!g{<uqpqh<!hqg<Gl<!
! ! hir<gigs<!sqlqtqg<Gl<!Ovilljs!uqg<Gl<!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</56?!h/w{</28!
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Nagan is responsible for intelligency  and  it  was  responsible for blinking, 
opening of eyelids and raising eye brows. 
 
7. Koorman 
“fqjlogim<Mr<!ogim<miuqkiEr<!ogit<Tl<!!
! ! Ofvig!uib<&Ml<!ohzZ{<miGl<!
gjlg<!ogim<Mr<!g{<uqpqg<G!&mh<!h{<[l<!
gim<sqobz<zir<!gi{<hqg<Gl<!uqpq!fQOviMl”;!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911/!
hi/w{</59?!h/w{</28!
 
Koorman is responsible for blinking of eyelids, yawning, closing mouth and  
strengthen of the body.  
 
8. Kirukaran 
“gjlg<!ogim<Mr<!gqVkvikqbqe<!G{f<kie<!
! ! gMfiU!fisqkeqx<!gsqU{<miOl!
gsqU{<mir<!gMl<hsqbqe<!ge<lR<!osz<Zl<!
! ! g{<{qOb!uqVk<kOziM!OhikziGl<!
KsqU{<mib<!Kl<lOzi!cVlZ{<miGl;”!
.!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</58?!h/w{</29!
 
Kirukaran is responsible for salivation,  nasal secretion and increased appetite.  
 
9. Devathathan 
“GsqU{<!mil<!Okukk<ke<!G{k<jkg<!Ogtib<!
! ! Gckzlib<s<!Osil<H!Lxqk<kqMok!ziOl!
Lxqk<kqMke<!olipqg<Gl<!OhiLbx<sq!bigq!
! ! LGtqklib<g<!g{<{qjeOb!Obic!Bziuqk<Kk<!
kiqk<kqMkz<!s{<jm!ogitx<!xig<gz<!Ohsz<!
! ! s{<mitg<!Ogihk<jk!d{<M!h{<{z”;!
.!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</58?!h/w{<29!
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The devathathan can produced lazziness and walking difficulties. It is  
responsible for eyeball movements, anger, argument and quarrel etc. 
 
10.Dhananjeyan 
kiqk<kqMfx<!xeR<!osbjes<!six<xg<!Ogtib<!
! ! sir<glib<!&g<gqeqe<X!kcg<Gf<!kiOe!
! kck<KOl!dml<ohz<zil<!uQr<gh<!h{<[l<!
! ! kf<kqvlib<!ge<ek<kqx<!sLk<kqvl<!Ohizk<!
! kqck<KOl!Sf<kvlib<!Ogim<mligqk<!
! ! kqv{<MOl!KR<sqb!gizf<!keqx<xie<!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</5:?!h/w{</2:!
 
It is responsible for swelling all over the body. It also produce tinnitus and 
blowing up the cranium on the third day after death. 
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THE FOLLOWING VAYU’S ARE AFFECTED IN 
CEGANAVATHAM 
1.VATHAM   
VATHAM FUNCTIONS 
1.    Viyanan Neck pain, restricted neck movements, radiating pain                                                                 
in neck and upperlimbs, tingling sensation, numbness 
and  giddiness. 
2.   Abanan Constipation 
3.   Samanan Indigestion, imbalance in the function of other vayu 
4.    Devathathan Sleeplessness 
 
2. PITHAM 
Pitham is formed by the element fire (thee). It maintains the body temperature. 
Pitham  regulates  the function of thermogenesis, metabolism, digestion and  
maintaining the skin  colour  and blood.  
 
Five types of pithams are, 
  
 
 
 
 
 
 
 
 
In Cegana Vatham  Analapitham may or may not be affected. Ranjagam may 
or may not be affected according to patient haemoglobin level Sathagam affected and 
there by difficulty in performing usual works. 
 
 
 
PITHAM FUNCTIONS 
1. Analagam Responsible for digestion 
2. Ranjagam Gives nutrition to blood. 
3. Sathagam  Responsible for willful 
activities. 
4. Prasakam Gives luster to   skin 
5. Alosakam   Gives strength to eyes 
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3. KAPHAM 
Kapham is formed by  earth and  water . It is cited to the head and neck. 
kapham represents feeling of cold, heaviness, mucous discharge and saliva. Five types 
of  kapham and their functions are, 
KAPHAM FUNCTIONS 
1. Avalambagam Responsible for respiration 
2. Klethagam It lubricates the blood 
3. Pothagam Responsible for taste sensation 
4. Tharpagam It acts as a coolant for eyes 
5. Santhigam It acts as a coolant for eyes 
 
In Cegana Vatham  patients Tharpagam  and Santhigam was affected,it can 
produce burning sensation of  eye and neck pain. 
 
UDAL KATTUGAL   
Seven udalkattugal and its function are given below.  
UDALKATTUGAL FUNCTIONS 
1. Saram  Strengthens the body and mind 
2. Senneer Preserves brightness boldness power and knowledge. 
3. Oon   Gives structure and shape to body. 
4. Kozhuppu Lubricates the joints 
5. Enbu Construction of body structure 
6. Moolai It is present in the bones and gives strength to them 
7. Sukkilam (or) 
Suronitham 
Meant for reproduction and inheritances. 
 
In Cegana Vatham  affected udalkattugal are, 
If Saaram  affected can produce tiredness of body. If Seneer affected can 
produce  anaemia is  present.  If Oon, Kozhuppu and Enbu affected can produce 
muscle wasting ,restricted neck movements and degeneration in cervical vertebrae 
and Osteophytic changes are presented in cehana vatham disease. 
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Thinaigal  ( Land ) 
Geographically land is divided into five 
“GxqR<sq!fqzOl!uiklir<!%Xl<!hijz!hqk<klkiR<!
osxqf<k!lVkR<!sqOzk<llkiR<!sqOzk<l!uik!Lz<jzbkil<!
fqjxf<k!ofb<kz<!uikhqk<kl<!fqzr<gtkje!lbg<gib<!
Zjxk<k!!uqbikq!gzf<kqVg<G!Lhib!lxqf<K!osb<uQOv” 
! ! ! !!!!!!.!ke<uf<kqvq!fic!
Vatham is mainly  provokes in kurinji,  mullai and neithal land. 
 
1. Kurinji (Hills  area) 
 1. Mountain and its sourroundings 
 2. Commonly seen in kabham and liver related disease.  
 
2. Mullai (Sylvantract) 
 1. Forest and its surroundings 
 2. Commonly produced  in pitham and vatham releated disease. 
 
3. Marutham (Agricultural land)  
 1. Fields and its surroundings 
 2. Ideal place for healthy living 
 
4. Neithal (Coastal area)  
 1. Ocean, Sea and its surroundings. 
 2. Commonly produced in vatham and liver disease. 
 
5. Paalai (Desert) 
 1. Desert and its surroundings 
 2. Vatha pitham and Kapham releated disease can occurred in this place.  
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Paruvakaalangal 
According to alteration of kaalam thannilai valarchi ,vetrunilai Valarchi in the 
disease can be diagnosed by, 
S.No Kaalam Kuttram State of kuttram 
1 
Kaarkaalam 
( Avani- puratassi) 
Aug 16-Oct 15 
Vatham 
Pitham 
Vetrunilai Valarchi 
Thannilai valarchi 
2 
Koothirkaalam 
(Iypassi-karthigai) 
Oct 16-Dec 15 
Vatham 
Pitham 
Thannilai Valarchi 
Vetrunilai valarchi 
3 
Munpani Kaalam 
( Markazhi - Thai) 
Dec 16- Feb 15 
Pitham Thannilai Adaithal 
4 
Pinpani Kaalam 
( Maasi - panguni) 
Feb 16-Apr 15 
Kapham Thanilai Valarchi 
5 
Elavenil Kaalam 
( Chithirai - Vaikasi) 
Kapham Vetrunilai Valarchi 
6 
Mudhuvenil Kaalam 
( Aani- Aadi) 
June 16-Aug 15 
Vatham 
Thannilai Valarchi 
Thanilai adaithal 
 
2.3.6.NOI KANIPPU VIVADHAM (DIFFERENTIAL DIAGNOSIS) 
 
Some other types of vatha disease  are mentioned  in different text books.It 
was more helpful in  differential diagnosis of ceghana vathm 
 
1. PANIKAMBA VATHAM 
lii<g<glib<!uiBUuib<!olb<fq!jxf<K!
! ! ubqXkeqx<!!hsqbqzi!Ki[!lx<X!
! fii<g<glib<!Rizk<K!fmg<jg!bx<X!
! ! fMg<glir<!jgbqv{<Mf<!kqlqV!L{<mil<!
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Di<g<gli!Bxg<glqz<zi!K{i<s<sq!bx<X!
! ! dkxqOb!siQvolr<G!Lzi<f<K!gi[l<!
! hii<g<glib<!uib<uqm<M!nzk<k!ziGl<!
! ! hi{qg<gl<h!uikk<kqe<!hir<G!kiOe!
! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
!!!!!! ! ! hi/w{</377?!h/w{</!212!
 
Clinical features are, 
1. Anorexia 
2. Tingling sensation and numbness of upper limbs 
3. Tremor of upper limbs 
4. Sleeplessness and dryness all over the body. 
   !
 
2. KANDA KIRAGA VATHAM:- 
The Clinical features are, 
“ujgbie!Gvzkjeh<!hx<xq!ofif<K!
! ! liOviM!hqmiqbqeqz<!uzqB{<migq!
Fgvie!siQvolz<zil<!ofif<k!px<xq!
! ! K[g<glib<s<!SuislK!Hxh<h!milz<!
Ljgbie!fiuiOk!&s<S!lixq!
! ! Lgk<kqOz!uqbi<jubigq!uqziOfi!U{<mil<!
hjgbie!ue<ek<jkh<!hVogim<miK!
! ! hiqg{<m!gqvgk<kqe<!h{<H!kiOe”!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
!!! ! hi/w{</414?!h/w{</!227!
!
1. Pain in the throat, chest and occipital bone. 
2. Anorexia 
3. Breathing through month 
4. Backache 
5. Perfuse sweating on face 
6. Loss of appetite 
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3. SIRAKAMBA VATHAM 
ohx<xqbil<!ohVjlbir<!giZr<!jgBl<!
ohVubqX!ofR<OsiM!uqvZ!&g<Gl<!
wx<xqbi!olxqgPk<K!olr<Gl<!hx<xq!
! ! Wg<glib<!ofif<KUml<!ohr<Gl<!uQr<gq!
dx<xqbi!&{Oufq!lqi<k<okMk<K!
! ! dXkqbib<!hqcg<gU!oli{ilziGl<!
sk<kqbib<!uib<gsf<K!lbg<g!liGl<!
! ! kiqk<kqm!oui{<{iK!Ohb<!uikf<!kiOe!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
!!!!!!!!!!!! ! hi/w{</387?!h/w{</!216!
 
The Clinical features  of Sirakambavathm are, 
1. Stiffness of neck 
2. Deafness 
3. Yawning 
4. Over Sleeping 
5. Titubation  in the head  
6. Difficulty in using  upper and lower  limbs. 
 
4. PEIVATHAM 
ohx<xqbil<!ohVjlbir<!giZr<!jgBl<!
! ! ohVubqX!ofR<OsiM!uqvZ!&g<Gl<!
wx<xqbi!olxqgPk<K!olr<Gl<!hx<xq!
! ! Wg<glib<!ofif<KUml<!ohr<Gl<!uQr<gq!
dx<xqbi!&{Oufq!lqi<k<okMk<K!
! ! dXkqbib<!hqcg<gU!oli{ilziGl<!
sk<kqbib<!uib<gsf<K!lbg<g!liGl<!
! ! kiqk<kqm!oui{<{iK!Ohb<!uikf<!kiOe!
! ! ! ! ! ! ! .!B,gq!juk<kqb!sqf<kil{q!911!
hi/w{</387?!h/w{</!216!
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The Clinical features are 
1. Pain and swelling in neck, upper and lower limbs 
2. Weakness of hand muscles,  
3. Vomiting 
4. Giddiness  
5. Swelling all over the body 
 
2.3.7.KAAPPU (PREVENTION) 
To Prevent Cegana Vatham, Avoid intake of excess sour, astringent and bitter 
taste foods and Sleep without pillows,to avoid holding neck in one position for a long 
period.   
1. Kaappu - Prevention 
 2. Neekam - Treatment 
 3. Niraivu - Restoration 
 
2.3.8.NOI NEEKAM (TREATMENT) 
The fundamental of siddha treatment is not only for the removal of physical 
illness, but also cured the mental illness. Treatment is considered with prevention and 
improvement of the general body condition. So ,it essential to know the disease the 
etiological factor, the nature of the patient, the severity of illness, the seasons and the 
time of the occurrence of the disease.It was noted in following lines are, 
 
Noi  neekam is based on, 
1. To bring the three dhosas in equilbrium 
2. Treatment of the disease by internal medicine  
3. Diet and advice 
4. Thokkanam 
5. Yoga 
6. Kanma nevarthi 
7. Bring the dhosa in Equilibrium 
 
“Ofib<fic!Ofib<Lkz<!fic!nK!k{qg<Gl<!
uib<fic!uib<h<hs<!osbz;” 
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“dx<xietUl<!hq{qbtUr<!gizLr<!
gx<xie<!gVkqs<!osbz;”! ! ! .!kqVg<Gxt<!
 
 The Siddha system of medicine is based on the mukkutra theory the treatment 
is mainly aimed to bring down the three dhosas to its equilibrium state and therby 
restoring the physiological condition of various thathukkal. 
 
“Lh<hq{q!lVuq!LxqU!ogit<!Gxqh<jh!
kh<hikxqBl<!ke<jlBl<!uikhqk<k!jubh<!
hqiqjuB!ljeukil<!
Wxq!bqxr<gq!-j{f<K!gzf<K!
lixq!lixq!uVR<!osb<jgbix<!hq{q!
Ofi<jlbxqf<K!fQm<M!lVf<Ok!
sQiqbkioles<!osh<Hui<”!
!
Line of Treatment 
The vitiation of vatham  is a prime factor of Cegana Vatham  .Purgation is  the 
first line of treatment in vatha diseases. This can be explained in Siddha 
Maruthuvanka churukkam.  
“uqOvsek<kiz<!uikl<!kiPl<!
nxqf<kqMl<!uikl<!nmr<G!lzk<kqeqz<!
! ! ! ! sqk<k!lVk<Kuir<g!SVg<gl</!
 
Internal Medicine: 
Appalakara chooranam - 2gm, twice daily after food with  water is cured 
ceganavatham,it was mentioned in Gunapadam thathu jeeva vaguppu text book, Page 
no 368. 
 
General Characteristics (ohiuni0BA4_uni0BC1uni0B95_uni0BCDuni0B95_uni0BC1ணuni0BAE_uni0BCD)  
Gmz<uikR<!$jz!ogickie!uikl<!
nmz<HvqB!jlb!lMg<Gl<!.!ofMubqx<xqe<!
dh<Hsg<kq!Oeim!dbv<Ge<l!Ofibgx<X!
lh<htg<!giv!lK!                                                      
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DIET 
Pathiyam 
“hk<kqbk<ki!Z{<miGl<!h{<ckx<Gh<!Ohvi{<jl!
hk<kqbk<ki!Z{<miGl<!hi{<ckr<gt<!.!hk<kqbk<jk!
uqm<mik!hq{qujggt<!uqk<kiqg<Gl<!uqm<cmju!
uqm<mix<!hxg<Gl<!uqje” 
.!Okjvbi<!ou{<hi (h/w{<:342) 
 
In Theriyar venba was  explained that the treatment as well as diet regimen 
was advised in vatha diseases (cehanavatham).  
 
Vatha Roga Pathiyam 
“HtqKui<!uqR<Sr<!gxqbix<!H,iqg<Gl<!uikl<” 
! ! ! ! ! .!hkii<k<k!G{!sqf<kil{q!
 
According to Pathartha chinthamani book is adviced the following tastes are 
avoid the  Cegana Vatham  ( sour and astringent). 
 
Vatha roga vasthukal:- 
Root of lily water  (pontederia veginalis) costus root (costus speciosus), honey 
colleted on branches of trees, black pepper (piper nigrum) gingely oil, asofoetida, 
leaves of clerodendron phlomoides, castor oil, black gram will cure vatha disease. 
 
 “osr<gPfQi<!Ogim<mf<Oke<!lqtG!fz<oz{<o{b<!
kr<G!ohVr<gibf<!kPkijp!.!obr<ogr<Gr<!
%m<M!!sqX!Lk<Kofb<!OkikqZPf<kqjugt<!
uim<M!l{qzk<jk!lkq”!
! ! ! ! ! hkii<k<k!G{!sqf<kil{q(h/w{</375)!
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THOKKANAM (MASSAGE THERAPHY) 
okig<g{l<! .!okig<G +!n{l<!
Thokku means skin.Anam means support/tones/heat 
  
Thokkanam act as directly on vascular, nervous, lymphatic and musculo 
skeletal system. It was helped to strengthening  the  physical and mental state. It also 
increases the vital power and provides relaxation. 
  
“okig<g{k<kqei!zqvk<kf<!Okiz<!Deqju!gm<G!
lqg<g!sUg<gqbR<!slQvEl<!Ohi!.!olb<gkqg!
Hm<cBxg<gl<!H{i<s<sq!bqju!gkqg<Gl<!
hm<m!njzs<s!zXl<!hii;”.!
! ! ! ! ! ! ! .!hkii<k<k!G{!sqf<kil{q!
 
Vatha diseases are relieved expecially by thokkanam.According to Theriyar 
maha karisal, 
  ! !
!! “li<keligqb!okig<g{k<kqe<!osbz<!uGh<hiOe!.!ski!
! fqk<kLl<!uikl<!hq{qk<k!hq{qh<jh!osh<OhOe”.!
.!Okjvbi<!lgi!giqsz<!
 
TYPES 
 Thattal  - Patting 
 Irukkal  - Tightening 
 Pidithal - Holding 
 Murukkal - Twisting 
 Kattal  - Typing 
 Azhuthal - Pressing 
 Ezhuthal - Pulling 
 Mallathal - Supinating 
 Asaithal - Shaking . 
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YOGA THERAPY 
• To unite the mind and soul. 
• Therapeutic yoga is  basically system of self treatment. 
• Yogasanam are reliable supportive therapy or sometimes play the main part of 
the treatment of vatha diseases. 
• The yogasanams are useful to not only revive the body but also strengthen the 
nervous, locomotor, digestive and  endocrine systems.  
 
Asanam 
Asanas are postures, which are performed by the physical body with the 
involvement of breath the mind, the intelligence, and these asanas help in balancing 
and harmonizing the basic structure of the human body.Our siddhars were well aware 
of the importance of the spine in relation to disease. Hence, they explained many 
asanas and postures, which were designed to make the spine more flexible and 
strengthen the neck muscles. 
 
The following asanas are advice to the patients to releive from the symptoms 
of Cegana Vatham . 
1. Bhujankaasana 
 Helps in keeping the dorsal spine elastic and strong. 
 Backache due to over strain can be releived. 
 Helps in considerable reduction of abdominal fat. 
 
 
 
 
 
 
 
 
 
 
 
     2. Maharasana 
 It gives complete relaxation to the muscles and is
Insomnia etc. 
 
 
 
 
 
 
3. Savasana 
 These asanas can be done after the neck pain is reduced considerably with 
drug treatment. 
 
 
 
 
 
 
4. Pavanomukthasana
 To get relief from constipation
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 useful in Hypertension, 
 
 and stengthan the abdominal muscles. 
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5.Arthakadi Chakkarasana 
 It gives a good lateral movement to the vertebral column and helps in keeping 
it flexible and strenthan the para spinal muscles.  
 
 
 
 
 
 
 
6.Ustrasana (The camel pose) 
 Promotes spinal circulation 
 Relieves vertebral pressure 
 
 
 
 
 
 
 
 
7.Gomukhasana (Cow face pose) 
 This helps is making the spine straight  
 It gives exercise to the lungs automatically. 
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8.Dhanurasana (The Bow Curve pose) 
 It makes spine and back muscles flexible and removes nervous weakness. 
 It helps in removing constipation and pitha disorders. 
 These asanas is contra indication to lumbar spondylitis and intra vertebral disc 
prolapse. 
 
 
9.Patchimuttasana 
 Stretches the back and spine 
 Stretches the shoulder and strengthen to respirotary muscles. 
 
 
 
 
 
 
The above mentioned are indicated to strenghthen the para spinal 
muscle and increased the motion of the vertebrae. 
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2.4.MODERN ASPECT - CERVICAL SPONDYLOSIS 
2.4.1.ANATOMY OF VERTEBRAL COLUMN 
The vertebral column forms back bone of the body. It is made up of 33 pieces 
of vertebrae and intervening intervertebral disc. The vertebral column, which lodges 
and protects the spinal cord, its meninges in a canal within it is called as vertebral 
canal. It is 60-70 cm length. It supports the body weight and transmits it to the ground 
through the lower limbs. 
 
The Curvatures of the spine: 
There are four curvatures in the vertebral column. They are two primary and 
secondary curvatures.The primary curvatures are the thoracic and sacral. They are 
convex posteriorly.The secondary curvatures are the cervical and lumbar. They are 
anteriorly convex. 
 
The cervical curvature becomes prominent when the child is able to hold its 
head up and fit upright. The lumbar curvature appears by 12-18 months after the child 
starts walking. A slight lateral curvature is seen in the upper thoracic region. 
 
Cervical vertebrae: 
• The cervical vertebrae are the back bone of the neck. The cervical segment of 
vertebral column contains 7 vertebrae. 
• The first second and the seventh are atypical and the third to sixth are typical. 
• They are smaller and delicate than the thoracic and lumbar vertebrae. 
• All the cervical vertebrae have a foramen in the transverse process known as 
foramen transversarium. This is identical to the cervical vertebrae. 
I - Cervical Vertebrae is called atlas. 
II - Cervical Vertebrae is called axis. 
VII - Cervical Vertebrae is called Vertebral prominence. 
• Intervertebral disc is located between C2-C7. Atlas and Axis vertebrae has no 
disc between them. At birth the disc occupy half the length of the cervical 
spine. In adults the length is one-third of the cervical spine and after the age of 
50 years it is reduced. 
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Palpable parts of cervical vertebrae: 
I. The transverse process of C1 through the anterior border of sterno 
cleidomastoid immediately below the tip of the mastoid process. 
II. The spine of C2 is in the nape of the neck 5cm below the external occipital 
protuberance. 
III. The spine of C7 Where the collor bone crosses the posterior medium line of 
the neck. 
 
Movements: 
Flexion, Extension, lateral bending. 
 
Movements of the Vertebral column: 
The greater thickness of the disc in the cervical region compared with thoracic 
region is associated with the greater individual range of movements occurring in those 
regions. 
Flexion, Extension, lateral flexion and rotation are possible in vertebral 
column. The following neck muscles are involved in neck movements. 
 
Movements Muscles Nerve Supply 
Flexion 
Sternocleidomastoid Accessory ventral rami of cervical 
spinal nerves C2, C3, C4 
Longus Capitis Cervical Ventral rami C1-C3 
Longus coli Cervical ventral rami C2-C6 
Rectus Capitis anterior C1 Ventral Ramus 
Extension 
Trapezius Accessory Nerve 
Erector spinae Dorsal rami 
Rectus capitis posterior 
major and minor 
Dorsal Rami C1 
Oblique capitis superior C1 – Dorsal ramus 
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Lateral  
flexion and 
rotation 
Scalene Cervical ventral rami C3-C8 
Sternocleidomastoid Acessory, ventral rami of cervical 
spinal nerves C2,C3,C4. 
Rectus Capitis C1 – ventral ramus 
Splenius Cervical dorsal ramus. 
Longus coli Cervical ventral rami C3-C8 
Levator scapulae Cervical ventral rami C3,C4,C5 
Longismus obliques 
capitis superior and 
inferior 
C1 Dorsal ramus 
 
2.4.2.DEFINITION 
Cervical spondylosis is a disorder characterised by degeneration of the 
intervertebral disc, with subsequent changes in the bones and soft tissues.  
Spondylosis is usually asymptomatic. Symptoms are usually manifested of 
encroachment of local neural  elements such as cervical nerve roots, spinal cord, 
vertebral artery (or) sympathetic nerves 
 
2.4.3.EPIDEMIOLOGY  
Cervical spondylosis is common condition that is estimated to account for 2% 
of all hospital admission.It is the most frequent cause of spinal cord dysfunction in 
patients older than 55 years.On the basis of radiologic findings ,90% of men older 
than 50 years and 90% of women older than 60 years have evidence of degenerative 
changes in the cervical spine.  
 
Evidence from a 2009 report indicated that cervical spondylosis with 
myelopathy was the most common primary diagnosis (36%) among elderly us 
patients treatment of a degenerative cervical spine between 1992 and 2005.The study 
,which looked at 156,820 hospital admissions for elderly medicare beneficiaries, also 
determined that fusion was the most common procedure (70%) performed in these 
patients for cervical spine degeneration , with 58% of the fusion being anterior. 
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International investigators in a study involving Ghanaians reported ,out of 225 
patients who carried loads on their head ,143(63.6) had cervical spondylosis ,and of 
the 80 people who did not carry load on their head ,29(36%) had cervical spondylosis. 
 
2.4.4.ETIOLOGY 
A. Degenerative Causes 
There are primary and secondary. 
Primary – sensibility 
 Genetic factors 
 Metabolic factors 
 Manual Labour 
Secondary – Osteo arthritis 
 Rheumatoid arthritis 
 Metastatic carcinoma 
 TB spine 
B. Trauma:- Whiplash injury 
 Road Traffic Accidents 
 Atheletic injury 
C. Hereditary factors:- 
 Congenital narrowing of the cervical spinal canal. 
 Segmental defets – Hemi vertebra, Fushed Vertebrae. 
D. Acquired narrowing of cervical spinal canal due to  
 Osteophytes 
 Ossified posterior Longitudinal ligament. 
 Facet joint hypertrophy (results foraminal stenosis and 
compression of root of radicular artery). 
 Hypertrophied ligamentun flavum (compress the cord during 
extension). 
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2.4.5.PATHOGENESIS 
Degenerative changes begins with intervertebral disc desiccation, which is 
associated with increase in the ratio of keratin sulfate to chondroitin sulfate. A long 
with desiccation, the nucleus pulposus shrinks, loses elasticity and becomes more 
fibrous due to the loss of water, protein and mucopolysaccharides during the aging 
process. Disc height is initially lost in the ventral portion of the disc, which results in 
a decrease in cervical lordosis. Unfortunately, this process results in positive feedback 
cycle due to the increase in forces applied ventrally and eventually may lead to 
kyphotic deformity.These early changes ultimately lead to the main 
pathophysiological process of cervical spondylosis, a reduction in sagittal spinal canal 
diameter. Additionally, these changes cause a transfer of axial load onto the facet 
joints, resulting in hypertrophy of those joints that further decreases the spinal canal’s 
diameter. 
 
The annulus fibrosis is thinner dorsally, thus making it easier for the nucleus 
pulposus to dissect through and cause disc herniations into the spinal canal. Preceding 
disc herniations, the peripheral fibers of the annulus fibrosis and sharpey’s fibers 
dissect from the vertebral body edges. 
 
Another early degenerative change is the posterior longitudinal ligament. 
Beginning to pull away from the vertebral bodies near the end plates. Eventually, 
abnormal cervical movement result either from the pain of disc herniation or annular 
protrusion, worsening degenerative changes or increased ligamentous laxity. Where 
the PLL peels off the dorsal vertebral body, reactive bone formation begins forming 
spondylotic bone spurs, which may be as large as the width of the vertebral body. 
These osteophytic growths may project into the intervertebral foramina. Some have 
reffered to these degenerative changes as cervical hyperostotic myelopathy. The 
increase in joint motion causes an acceleration of osteophyte growth, and this is most 
pronounced at C5-C6 and C6-C7. 
 
As expected, these two levels are also the most often affected by spondylosis 
with C6-C7 affected more commonly than C5-C6. The growth of osteophytes, along 
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with degenerative changes, leads to decrease in sagittal spinal canal diameter, the 
main pathophysiological process in cervical spinal spondylosis. 
 
In addition to the above described osteophytic and degenerative changes, a 
third modality that causes spinal canal narrowing is congenital cervical stenosis. The 
average cervical spondylotic patient’s spinal canal is 3mm smaller than the average 
population. More pronounced narrowing is observed in congenital stenosis patients. 
The average adult spinal canal diameter has been reported to be 17 to 18mm between 
C3 and C7. These diameter patients will suffer from spondylosis and the range 
reported is 13-14.8mm. In patients with congential stenosis these degenerative 
changes are magnified leading to earlier onset of myelopathy. 
 
2.4.6.CLINICAL   FEATURES 
1. Pain in the neck, radiating to the shoulder blades, top of the shoulders, upper 
arms and hands or back of the head. 
• Numbness and tingling sensation in the arms, hands and fingers, some 
loss of feeling in the hands and impairment of reflexes.  
• Crunching sounds with movement of the neck or shoulder muscles. 
• Neck stiffness 
• Headache 
• Muscle weakness and deterioration. 
• Dizziness and unsteady gait. 
 
Common clinical syndromes associated with cervical spondylosis 
include the following:- 
(i) Cervical radiculopathy 
Compression of Cervical nerve roots leads to ischaemic changes that cause 
sensory dysfunction (Radicular pain) and motor dys function (weakness). 
Radiculopathy most commonly occurs in persons aged 40-50yrs. An acute herniated 
disc or chronic spondylotic changes can cause cervical radiculopathy and myelopathy. 
The C6 root is the most commonly affected one because of the predominant 
degeneration of the C5-C6 interspace. The next common sites are at  C6-C7. There is 
also referred pain and tenderness along the medial border of the scapula. 
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(ii) Cervical myelopathy 
It may be precipitated by a large central disc herniation but is more commonly 
the result of spondylotic changes superimposed on a congenitally narrowed canal. 
Dorsomedial herniation of disc and the development of transverse bony bars or 
posterior osteophytes may results alone or in combination with pressure on the spinal 
cord or the anterior spinal artery which supplies the anterior 2/3 of the cord. 
 
It has an insidious onset, which typically becomes apparent in persons aged 
50-60 years. Upper motor neuron signs develop in the limbs with spasticity of the 
legs. Sensory loss in the upper limbs is common. Tingling and numbness with 
progressive clumsiness. 
 
THE SITE OF SENSORY DISTURBANCES WITH INDIVIDUAL 
ROOT 
Nerve 
root 
Dislevel Symptoms 
C3 C2-C3 
Pain and numbness in  the back of the neck mastoid 
process, and pinna of ear. 
C4 C3-C4 
Pain and numbness in the back of the neck, levator scapulae 
and anterior chest. 
C5 C4-C5 
Pain in the neck,  Tip of the shoulder, anterior arm, 
numbness over middle of the body, deltoid muscle. 
C6 C5-C6 
Pain in the neck, shoulder, medial border of the scapula, 
lateral arm, dorsal forearm, numbness in tip of thumb or on 
dorsum of hand over first dorsal interosseus muscle. 
C7 C6-C7 
Pain in the neck, shoulder, medial border of scapula, lateral 
arm, dorsal forearm, sensory change in index and middle 
finger. 
C8 C7-T1 
Pain in the neck, medial border of scapula,medial aspects of 
arm and forearm. Sensory change in the ring and little 
fingers.  
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THE MOTOR SYMPTOMS AND SIGNS                        
(INCLUDING REFLEXES) 
Nerve 
Root 
Disc level Weakness-Reflex change 
C3 C2-C3 
Not readily detectable weakness or reflex change except 
by EMG. 
C4 C3-C4 
Not readily detectable weakness or reflex change except 
by EMG. 
C5 C4-C5 
Weakness of extension of arm and shoulder particularly 
above 90o,wasting of deltoid muscle ,no reflex change.  
C6 C5-C6 Weakness of biceps muscle, diminished triceps reflex. 
C7 C6-C7 Weakness of triceps muscle, diminished triceps reflex. 
C8 C7-T1 
Weakness of triceps and small muscles of hand.No 
reflex change. 
 
PHYSICAL EXAMINATION 
The following signs are positive in cervical spondylosis.The signs are, 
1. Spurling sign 
Radicular pain is exacerbated by extension and lateral bending of the neck 
toward the side of the lesion. Which result in further foraminal compromise. 
 
2. Lhermitte’s sign 
The generalized electric shock sensation is associated with neck extension. 
 
3. Hoffman sign 
Reflex contraction of the thumb and index finger occurs in response to nipping 
of the middle finger. This sign is evidence of an upper motor neuron lesion. A 
Hoffman sign may be insignificant if present bilaterally. 
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4. Axial compression test 
Pain that is elicited by axial compression. 
 
5. Shoulder abduction test 
Relief of cervical radiculopathy by abduction. 
 
6. Valsalva manouevre 
Increase the radicular symptoms. 
 
2.4.7.COMPLICATION  
The following Complications is commonly occurred  in untreated 
cases 
1. Pseudo arthrosis 
2. Graft displacement. 
3. Neurological injury 
4. Spastic gait 
5. Quadriplegia  
6. Injury to other structures. 
 Recurrent laryngeal Nerve. 
 Superior laryngeal Nerve. 
 Carotid artery. 
 
2.4.8.DIFFERENTIAL DIAGNOSIS 
1. Thoracic outlet syndrome 
There is compression of lower trunk of brachial plexus by an anomalous band 
that connects the transerve process of C7 within the first rib. Neurologic deficit 
include weakness of intrinsic muscles of the hand and diminished sensation over the 
palmar aspect of fourth and fifth digits. 
 
2. Brachial plexus and nerve injury 
Pain from injury to the brachial plexus or peripheral nerves can be confused 
with pain of neck origin. Infiltration of peripheral nerves by neoplasm may occur in 
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lower trunk of brachial plexus and produce shoulder pain that radiates down the arm. 
There is numbness of the fourth and fifth fingers with weakness of intrinsic muscles 
of the hand supplied by ulnar and median 
 
3. Refered pain 
Cardiac ischemia causes left sided brachial neuralgia. In those patients, 
diagnosis depends on the history, examination and abnormal findings in ECG. Sub – 
diaphragmatic lesions cause right sided pain. The Gall bladder lesions cause right 
sided brachial neuralgia. The diagnosis depends upon the history examination and 
investigations. 
 
4.   Syringobulbia: 
Dissociated sensory loss on the face, palatal palsy, Horner’s syndrome, 
nystagmus, Kyphoscoliosis, pescavus and spina bifida are then found. 
 
5. Syringomyelia: 
Long history of neck and arm pain, depending on the site of the syrinx, 
ascending or descending spinal pathways may be affected which can lead to a spastic 
paraparesis or sensory deficit in the upper and lower extremities pressure on the 
anterior horn cells can lead to fasciculation and atrophy of the upper limb muscles. 
 
In the lower extremities hyperflexia in the legs and extensor plantar responses 
are common. Charcot joint in the shoulders, elbows or knees are common in advances 
cases. 
 
6.  Tumours of the spinal canal 
(a) Extra dural or epidural tumour 
Commonest extra dural tumours are the spinal metastasis. The symptoms are 
local pain, radiating pain that is exacerbated by coughing; sneezing or straining pain 
and local tenderness often proceed. 
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(b) Intra dural Tumours: 
(i) Intra medullary tumours: 
  Dissociated sensory loss in the segments of tumour origin and spring of 
posterior column sensory function. Later spinothalamic tracts may be involved. The 
sacral segments may be spared. Atrophy in the appropriate segments due to anterior 
horn cells involvement. 
(ii) Extra medullary tumours: (Meningiomas neurofibroma) 
Local back pain, sensory loss below the level of the pain, weakness and 
bladder and bowel dysfunctions. 
 
7. Tabesdorsalis: 
Fleeting and respetitive shooting pains occurring mostly in the legs. Loss of 
reflexes in the legs, impaired position and vibration sense gives severe ataxic gait. 
Romberg,s test is positive. Aygyll Robertson pupils constitute a typical tabetic facies. 
 
8. Epidural abscess: 
This condition can occur as a complication of operation or lumbar puncture. 
Spinal osteomyelitis cause abscess formation Unexplained fever and mild spinalache, 
later radicular pain occurs. As the abscess expands it causes and compression with 
transverse and usually complete transaction syndrome. 
 
2.4.9.INVESTIGATIONS: 
1. Plain – x ray of cervical spine antero posterior and lateral views. 
- Intervertebral disc space narrowing 
- Osteophytic  changes 
- Altered  Lordosis 
- Degeneration in facet and vertebral joints. 
- Foraminal stenosis, central stenosis. 
- Sclerosis in the vertebrae. 
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2. CT – SCAN (Computerised Tomography) 
- Confirms degenerative changes 
- May demonstrate posterior osteophytes and disc 
herniation. 
 
3. CT – MYELOGRAPHY: 
- Useful for localisation of cord compression 
 
4. MRI -  (MAGNETIC RESONANCE IMAGING: 
- To asses cervical canal diameter, to find out severity  
of the compression 
 
5. EXAMINATION OF CSF 
- Increased  high protein. 
 
2.4.10. TREATMENT AND MANAGEMENT: 
1.  Medication:   a) Analgesic and muscle relaxant 
b) Corticosterone injection 
     2. Physiotheraphy  : To relieve pain and enchance   
              movement of the neck. 
    3. Conservative methods 
    4. Surgical management 
(i) Cervical Traction: 
Vertebral traction should be the first choice of pain relief for patients suffering 
nerve root pain. Intermittent sustained traction is carried out after careful positioning 
has localized the involved segment in such cases the treatment atleast once a day is 
essential prolonged pain relief will take several days to obtain. 
 
Cervical traction provides positive patient response and can relieve the pain 
associated with certain neck disorders. It applies a stretch to muscles, ligaments and 
tissue components of the Cervical spine. It provides relief by promoting.  
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Seperation of the intervertebral joint space which contains the disc and may 
reduce a “bulge or impingement of structures for use in the foramen. It is not 
indicated for use in condition of instability such as with “Whiplash injury”. It is most 
commonly used when the patient is in the supine position with the neck placed at 200-
300 of flexion. Using traction in this position helps stretch the posterior neck muscles 
and facilitate intervertebral seperation, Which relieves pressure that may be pinching 
nerves, therefore promoting muscle relaxation and intervertebral separation. 
 
(ii) Cervical collar/ Cervical Bracelet: 
Cervical collar are advised to wear temporary collar for day time to restrict 
movement and a soft collar for support at night. A patient who is given a collar should 
be advised that the restriction in neck movement will alter other proprioception, for 
example he will need to take care in the dark or on entering darkened rooms when he 
may lose his balance. A patient wearing a collar should not drive because judgement 
of relative distance will be impaired. In the case of vertebrobasillar insufficiency 
cervical collar may be advised to the suffers according to the following exercises are 
advised in Cegana Vatham  cases, 
 
I. Neck Bending 
 Sit with both legs straight. 
 Place the palms on the floor by the side of the buttocks. 
 Keep the back, neck and head straight. 
 Close the eye 
 
Stage - I (Forward - Back ward movement) 
 Slowly move the head forward and try to touch the chin to chest. 
 Then move the head as far back as comfortable.   
 Try to feel the stretch of the muscles in front and back of the neck and the 
loosening of the spine in the neck. 
 Practice 10 times. 
 Inhale on the backward movement and exhale on the forward movement 
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Stage - II (Bending to Right and left) 
 Close the eyes and face directly forward 
 Slowly bend the head to the right and try to touch the right ear to the right 
shoulder. 
 Bring the head back to the normal position. 
 Then bend to the left side and try to touch the left ear to the left shoulder in 
the same fashion. Lift the head to the centre. 
 This is one round practice 10 rounds 
 Inhale on the upward movement and exhale on the downward movement. 
 
Stage - III (Turning the head to Right and left) 
 Keep the head upright and eyes closed. 
 Gently turn the head to the right so that the chain is in line with the right 
shoulder. 
 Slowly turn the head to the left through the centre till the chin is in line 
with the left shoulder. Bring the head to centre. 
 This is one round practice 10 rounds. 
 Inhale while turning to the front. Exhale while turning to sides. 
 
Consider these follows 
Move the head as far as comfortable. Do not strain. 
 Keep the shoulders relaxed and unmoved. 
 Feel the release of tension in the neck muscles and the shoulder muscles.  
 
Benefits 
 These exercise reduced neck pain,strengthen of the  neck and shoulder 
muscles. 
 
2. Neck Rotation 
Stage - I (Half Rotation) 
 Relax the head bending forward. 
 Bring the right ear to the right shoulder in a circular way. 
 Bring the left ear to the left shoulder in a Circular bending the head 
forward. 
 Now relax the head forward again in a circular way and finally lift the 
head to normal position. Thi
 Repeat 10 rounds clock wise and 10 rounds anti 
breathing. 
 
Stage II (Full rotation)
 Relax the head forward trying to touch the chin to the chest.
 Slowly rotate the head in as large a  circle
the chin tucked in. 
 
The  diagrammatic  presentation of  neck  exercises
  
 
 
 
I 
III 
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SUMMARY: 
I. Neck Flexion and Extensions 
II. Head Tilt 
III. Neck Rotation 
IV. Neck Retraction 
V. Shoulder Rolls 
VI. Neck Extension and Flexion 
VII. Full Rotation 
VIII. Side Bending 
IX. Neck Stretching (Right and Left Side) 
X. Sternocleidomastoid Stretching 
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CHAPTER -III 
MATERIALS AND METHODS 
3.1.STUDY AREA AND SETTING   
The study period was covered from June 2017 to July 2019 at the Govt. 
Siddha Medical College and Hospital, Palayamkottai- 627 002, Tirunelveli, Tamil 
Nadu. Before  starding this  study was  getting the permission from  Indian Ethical 
Commitee.  
 
3.2.STUDY DESIGN 
The study design is a prospective open labelled Phase-II non randomized 
clinical trial of Appalakara chooranam  in Cegana Vatham  (Cervical spondylosis) 
study. The included selection were newly diagnosed and already  known diagnosed  
cervical spodylosis patients with or without taking treatment.  A written informed 
consent form was recruited in the study. The purpose of the study was explained to 
the patients before administration of trail drug.  The patients Information, life style, 
anthropometric measurements and Siddha parameters were recorded.   
 
The total number 40 patients, equally in both genter and  age between 30 to 60 
were included  for  this study. All  selected patients were treated  the trail drug for 30 
days. All the relavant findings are recorded  at end of the study period (30 days).  
 
 3.3.SELECTION OF THE DRUG 
 The  Appalakaram (Sodium carbonate) is available in three  types 
varieties,according to siddha  text books was  mentionend  types of applakaram 
,namely  carbonates,subcarbonate of soda and soda carbonas impura(sodii carbonas 
impura).The Applakkaram was collected from Madurai siddha traditional medical 
shop. Applakaram was confirmed by siddha pharmacologist of PG Gunapaadam 
department in GSMC ,Palayamkottai and chemical authentication by Chemist, 
Department of chemisty, Sadakathullah Appa College,Tirunelveli. 
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3.4.SELECTION OF THE PATIENTS 
The Clinical study on Cegana vadham was carried out in the post graduate 
department of Pothu Maruthuvam, Govt Siddha Medical College, Palayamkottai. In 
this study 20 patients were treated as Inpatients and the other 20 as Outpatients,totally 
40 patients were taken from this study.  
 
3.4.1.INCLUSION CRITERIA 
• Age: 30 – 60 years 
• Sex:  Both Male and Female 
• Willing to participate in trial and signing consent form by fulfilling the 
conditions of Proforma 
• Neck pain radiating to upper limb with or without numbness, giddiness and 
neck stiffness 
• Restriction neck movement 
• Willing for doing laboratory investigations and X-Ray imaging. 
• The neck disability index score should be equal or greater than 40%. 
 
3.4.2.EXCLUSION CRITERIA 
Cervical rib 
• Trauma 
• Systemic hypertension 
• Diabetes mellitus 
• Chronic kidney disease 
• Tuberculosis in spine 
• Ischaemic heart diseases 
• Pregnancy and lactation 
• Neoplasms 
• Patients with any other serious systemic illnes 
• Congenital anomalies of spine 
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The detailed history was taken from the patient about: 
 Occupation 
 Socioeconomic status 
 Psychological condition 
 Diet and other habits 
 Trauma 
 
3.4.3.Diagnosis: 
The diagnosis was made by following siddha diagnostic methods are Nilam, 
Kaalam, Poriyalaridhal, Pulanalarithal, Vinaadhal, Mukkutra nilaigal, Udal Thathukal 
Nilai and Envagai Thervugal. Its  correlated in  modern medicine was cervical 
spondylosis. It is confirmed by the Radiological examinations (x-ray cervical spine 
(or) MRI and CTS. 
 
Assesment of result: 
The result were assessed on the basis of symptoms and Neck disability index 
scale . 
 
Neck Disability Index: 
 This questionnaire has been designed to give us information as to how your 
neck pain has affected your ability to manage in everyday life. Please answer 
every section and mark in each section only the one box that applies to you. 
The index score was recorded by separate working sheet (Annexure) 
 
Score: /50 Transform to percentage score x 100 = %points 
• Scoring: For each section the total possible score is 5: if the first statement is 
marked the section score = 0, if the last statement is marked it = 5. If all ten 
sections are 
• completed the score is calculated as follows: Example:16 (total scored) 50 
(total possible score) x 100 = 32% 
• If one section is missed or not applicable the score is calculated: 16 (total 
scored) 45 (total possible score) x 100 = 35.5% 
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• Minimum Detectable Change (90% confidence): 5 points or 10 %points 
•  NDI developed by: Vernon, H. & Mior, S. (1991). The Neck Disability Index: 
A study of reliability and validity. Journal of Manipulative and Physiological 
Therapeutics. 14, 409-415 
 
3.4.4.INVESTIGATIONS : 
The following investigations were done in all selected patients in laboratory of 
Govt. Siddha Medical College, Palayamkottai,. and  private laboratory. 
 
Blood: 
 Total WBC Count 
 Differential WBC count 
 Erythrocyte Sedimentation Rate 
 Haemoglobin estimation 
 Estimation of Sugar 
 Estimation of creatinine 
 Estimation of Urea 
 Estimation of Cholesterol. 
. 
Urine: 
 Albumin 
 Sugar 
 Deposits 
 
Radiological Investigations : 
 X-Ray cervical spine (AP and Lateral View) 
 
Other Investigation 
 MRI –cervical spine (In selected cases) 
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3.5.TREATMENT AND MANAGEMENT 
All the patients were treated with the following  line of treatment.Appalakara 
chooranam -2 gm  twice a day after food with  water (internally)  is given for 30 days 
till  end of the trement period.  All the patients were adviced to dietary regimen. 
Yogasana and exercise were adviced along with oral medicine. 
 
3.5.1.Preparation of Trial Medicine (Annexure) 
The  mineral preparation of Appalakara chooranam   have been selected from 
the Classical Siddha literature. Reference: GunapadamThathu Jeeva Vaguppu 
Pagam II&III Page No.368.  
 
3.5.2.Collection and authentication of Trial Medicine (Annexure) 
 The  Appalakara chooranam   was  collected from the Nagarkovil & Madurai 
Siddha medical shop, Tamilnadu. The mineral will be identified and authenticated by 
the Chemist ,Sadakathullah Appa College and Gunapadam experts at Government 
Siddha   College and Hospital, Palayamkottai,Tirunelveli - 627002. 
 
Preclinical Analysis of Trial Medicine 
All the preclinical studies of the study drug which have been included in  Bio 
chemical and pharmacological studies and cross checked before starting the 
treatment.The Biochemical analysis were done in Dept. of Biochemistry, GSMCH, 
Palyamkottai.   The pharmacological activities- Anti-Infllammatory,  Analgesic,Anti 
ulcer, Acute and sub-acute toxicity, and  Anti microbial activities were  carried out in 
this study.  studies were done in  K.M. College of Pharmacy, Madurai -625107.  
 
3.5.3.Ethical Review 
The study was conducted in accordance with the ethical principles that are 
consistent with Good Clinical Practice guidelines and obtained prior approvals before 
start of the trial from the Institutional Ethics Committee of GSMCH, Palayamkottai 
(GSMC-IV-IEC/2017/BR-I/06/29.05.2017) and Institutional animal ethical 
committee (IAEC) of K.M. College of Pharmacy, Madurai 
(TNMGRMU/KMCP/IEAC/22/2018).  The trial was applied and approved by the  
Clinical Trial Registry of India [CTRI/2018/03/01268 (Registered on 20/03/2018) 
Trial Registered Prospectively]. 
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3.5.4.Study Enrolment   
Participants were informed in Tamil language, regarding the trial, the expected 
benefits and their right to opt-out of trial at any time without pre judice.  Informed 
written consent was obtained from each participant, prior to his/her inclusion into the 
trial.  
 
Before treatment the trial all the subjects were selected based  on Neck 
Disability Index  Score  should be equal( or) greater than 40%. All subjects of age 
range between 30-60 years .  
 
The subjects with history of serious adverse effects or hypersensitivity 
reactions to the medication such as rashes, diarrhoea, vomiting etc., and history of 
treatment with  active liver disease or hepatic dysfunctions, higher serum creatinine (> 
2.5 mg/dl) and serious or unstable medical or psychological condition are excluded 
from the study.   
 
During the visit, body weight, blood pressure, cardiovascular,neurological  
and respiratory system were  clinically recorded . During the treatment any adrverse 
reaction or side effects of patients, immediately to inform patient and 
pharmacovigilance committee. At the end of the study period, all the patients were 
instructed to follow diet control, regular exercise, yoga, meditation and bed rest to 
pursue the further treatment in the PG, Pothu Maruthuvam OP for the follow up study. 
 
3.5.5.Statistical Analysis  
All data were analysed using the SPSS 20.0 (IBM). Data were expressed as 
means and standard deviation. The significance of the difference between the means 
of the baseline and the final examinations was tested using the paired “t” test. A 
probability value of <0.05 was considered to be statistically significant. 
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CHAPTER - IV 
RESULTS AND OBSERVATIONS 
4.1.PRE CLINICAL STUDY 
4.1.1.ANTI-INFLAMMATORY ACTIVITY 
Evaluation of carrageenan induced Anti-inflammatory 
activity of Siddha formulation Appalakara chooranam in  
Albino wistar rats. 
Table 1. Effect of siddha formulation Appalakara chooranamon Carrageenan Induced 
Rat Paw Edema.  
 
Treatment 
 
Dose 
(mg/kg, p.o.) 
 
Mean inc rease 
in paw volume 
(ml) 
% Decrease 
in paw 
volume 
Normal control 10ml/kg saline 0.95 ± 0.08 - 
Toxic control 0.1 ml, 1% carrageenan 3.30 ± 0.20*a - 
Standard control 10mg/kg Indomethacin 1.35 ± 0.10*b 59.09% 
Treatment control 100mg/kg Appalakara  
chooranam 
1.42 ± 0.15*b 56.96% 
Treatment control 200mg/kg Appalakara 
chooranam 
1.36 ± 0.12*b 58.78% 
 
• Values are expressed as mean ± SEM. 
• Values were compared by using analysis of variance (ANOVA) followed by 
Newman-Keul's multiple range tests.   
• * (a) Values are significantly different from normal control G1 at P<0.01. 
 
* (b) Values are significantly different from Toxic  control G2 at  P<0.01. 
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Table 2. Effect of siddha formulation Appalakara chooranamon Carrageenan Induced 
Pleurisy in Rats. 
Treatment 
Dose 
(mg/kg, p.o.) 
Pleural exudates 
(ml) 
Leukocytes 
(×103 cells/ml) 
Normal control 10ml/kg saline 0.11±0.03 0.35±0.02 
Toxic control 0.1 ml, 1% 
carrageenan 
0.37±0.10*a 4.18±0.34*a 
Standard control 10mg/kg 
Indomethacin 
0.13±0.04*b 0.45±0.05*b 
Treatment control 100mg/kg 
Appalakara 
chooranam 
0.20±0.07*b 0.52±0.07*b 
Treatment control 200mg/kg 
Appalakara 
chooranam 
0.14±0.05*b 0.50±0.05*b 
 
• Values are expressed as mean ± SEM. 
• Values were compared by using analysis of variance (ANOVA) followed by 
Newman-Keul's multiple range tests.   
• * (a) Values are significantly different from normal control G1 at P<0.01. 
 
* (b) Values are significantly different from Toxic  control G2 at  P<0.01. 
 
Anti-inflammatory Activity of siddha formulation Appalakara chooranam 
The effect of siddha formulation Appalakara chooranam on carrageenan-
induced edema in rats is shown in Table 1. The results obtained indicate that the 
siddha formulation Appalakara chooranam had significant anti-inflammatory 
activity in rats. The siddha formulation Appalakara chooranamreduced the edema 
induced by carrageenan by 56.96% and 58.78%  on oral administration of 100 and 
200 mg/kg, as compared to the untreated control group. 
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Indomethacin at 10 mg/kg inhibited the edema volume by 59.09%. The effect 
of siddha formulation Appalakara chooranam on carrageenan-induced pleurisy in 
rats is shown in Table 2. The volume of pleural exudates in the toxic control group 
was 0.37±0.10 ml. Animals treated with the siddha formulation Appalakara 
chooranam (100 and 200 mg/kg, p.o.) decreased the pleural exudates to 0.20±0.07 ml 
and 0.14±0.05.Treatment with Indomethacin (10 mg/kg, p.o.) produced the exudates 
of 0.13±0.04 ml. The leukocyte count for the control group was found to be 
4.18±0.34×103 cells/ml. Animals treated with the siddha formulation Appalakara 
chooranam and standard produced a leukocyte migration of 
0.52±0.07×103,0.50±0.05X103 and 0.45±0.05×103 cells/ml, respectively. 
 
DISCUSSION 
Due to the increasing frequency of intake of NSAID’s and their reported 
common side effects, there is need to focus on the scientific exploration of siddha 
formulation drugs having fewer side effects. So, there is a continuous search for 
indigenous drugs, which can provide relief to inflammation. Carrageenan induced 
inflammation is a biphasic phenomenon. The first phase of edema is attributed to 
release of histamine and 5-hydroxytryptamine. Plateau phase is maintained by kinin 
like substances and second accelerating phase of swelling is attributed to 
prostaglandin like substances. The knowledge of these mediators involved in different 
phases is important for interpreting mode of drug action.The tests performed with the 
siddha formulation Appalakara chooranamin the pleurisy model showed that the 
siddha formulation Appalakara chooranam behaves as an inhibitor of leukocyte 
migration and the formation of pleural exudates when given orally, as reported earlier. 
Thus it can be concluded that the siddha formulation Appalakara 
chooranampossess significant anti-inflammatory activity in rats. Further studies 
involving the purification of the prerpation and the investigations in the biochemical 
pathways may result in the development of a potent anti-inflammatory agent with a 
low toxicity and better therapeutic index. 
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4.1.2  ANALGESIC ACTIVITY 
Evaluation of Analgesic Activity of Siddha formulation Appalakara chooranam in 
Animal Models 
Analgesic activity 
Acetic acid-induced writhing test 
The acetic-acid writhing test was performed using the reported procedure 
Groups of rats (n=6), were administered with100 and  200 mg/Kg of siddha 
formulation Appalakara chooranam, 10 mg/Kg Diclofenac as positive control group 
and 1 mL distilled water as negative control group. After 30 minutes the animals were 
administered with i.p. injection of 0.1 mL acetic acid (0.6%). Then the count of 
abdominal contractions of animals during 30 minutes after acetic acid injection was 
reported and the Percentage Analgesic Activity (PAA) was calculated by using the 
following formula: 
PAA = ((C- CD)/CD) ×100 
C = Mean of contractions’ count in animals treated with different doses of 
siddha formulation Appalakara chooranam and Diclofenac sodium  
CD = Mean of contractions’ count in animals served as negative control 
Statistical analysis 
The results are reported as mean ± S.E.M. The statistical analyses were 
performed using one way analysis of variance (ANOVA). Group differences were 
calculated by post hoc analysis using Tukey’s test. For all tests, differences with 
values of P<0.05 were considered significant. 
 
Results 
Acetic acid-induced writhing response 
The second study showed that the application of different doses of siddha 
formulation Appalakara chooranam had significant analgesic effects in the animals 
under investigation. The results of doses 100 and 200 mg/Kg were significant and 
comparable with the effect of Diclofenac sodium in analgesic activity (Table 1). 
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Table 1. Effects of siddha formulation Appalakara chooranam on acetic acid–
induced writhing response (N=6 in each group). 
Groups Treatment 
(number of 
writhing 
movements) 
(Mean ± S.E) 
Percentage % 
Group I Distilled water 28.00 ± 2.40 - 
Group II Diclofenac sodium 
10mg/kg 
5.65 ± 0.85*b 
 
79.82% 
Group III 100mg/kg 
Appalakarachooranam 
15.00 ± 1.60*b 46.42% 
Group IV 200mg/kg Appalakara 
chooranam 
13.05 ± 1.25*b 53.39% 
• Values are expressed as mean ± SEM. 
* (b) Values are significantly different from Toxic  control G2 at  P<0.01. 
 
Discussion and conclusion 
The analgesic activity was assessed by writhing test which has been reported 
to be useful for investigation of peripheral antinociceptive activity and performed as a 
chemical pain model . The siddha formulation Appalakara chooranam demonstrated a 
dose-dependent, significant antinociceptive activity in animal models of pain. Acetic 
acid believed to increase the PGE2 and PGF2α in peritoneal fluid . The analgesic 
activity shown in models of pain is indicative that siddha formulation Appalakara 
chooranam might possess centrally and peripherally mediated antinociceptive 
properties.  
 
Chemical components of siddha formulation Appalakara chooranam such as 
flavonoids, saponins or phenolic compounds may be responsible for the 
antinociceptive activities of this formulation. Since the findings of this study revealed 
a significant analgesic effect of the siddha formulation Appalakara chooranam, it can 
be concluded that terpenoids and specially saponins of siddha formulation Appalakara 
chooranam may be responsible for the observed analgesic effect which should be 
proved by further investigations.  
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It can be concluded that possesses anti-nociceptive properties which are 
probably mediated via inhibition of prostaglandin synthesis as well as central 
inhibitory mechanisms which may be of potential benefit for the management of pain 
and inflammatory disorders. 
 
4.1.3. ANTI ULCER ACTIVITY 
EXPERIMENTAL DESIGN 
GROUP NO TREATMENT DRUG /DOSE 
Group-I NORMAL CONTROL CMC 1% ( 1ml) 
Group-II ULCER CONTROL ASA 200mg/ kg 
Group-III STANDARD CONTROL OMEPRAZOLE  2mg /kg 
(Half hour before ASA 
administration) 
Group-IV TREATMENT 
CONTROL 
Appalakara 
chooranam100mg/kg orally 
(Half  hr before ASA 
administration) 
Group-V TREATMENT 
CONTROL 
Appalakara chooranam 
200mg/kg orally (Half  hr 
before ASA administration) 
 
ASPIRIN INDUCED &PYLORIC LIGATION ULCER MODEL 
 The albino rats were divided in to five groups, each group contains six 
animals. The study was carried out for four days after administration of the treated 
dose 30 min after ,the rats were treated with aspirin 200mg /kg.  This process was 
carried out for three days, on the third day after administration of drug the rats were 
subjected to fasting. On the next day pyloric ligation was made. The rats were 
sacrificed four hrs later by cervical dislocation and the esophagi were clamped ,the 
stomach was exposed carefully , opened along the greater curvature , the luminal 
contents were removed , the total volume of gastric secretion , total acidity, free 
acidity were estimated by titration method. 
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The ulcer index was calculated according to the method of gangrly and 
Bhatnagar[4].the lesions were counted with the aid of hand lens (10x) and each gives a 
severity rating as follows. 
 
ULCER SCORE DESCRIPTIVE OBSERVATION 
0 Normal colored stomach 
0.5 Red coloration 
1 Spot ulcers 
1.5 Haemorrhagic  streak 
2 Ulcers 
3 Perforation 
  
 Mean ulcer score for each animal was expressed as ulcer index. The 
percentage of ulcer inhibition was determined as follows  
Protection of ulcer (%) =   Control mean ulcer index- test mean ulcer index × 100 
                                                           Control mean ulcer index  
# values are expressed as MEAN ± SEM ,values were find out by using one 
way ANOVA followed by Newman  kevel’s multiple range test , probability value < 
p.0.01 was considered significant. 
 
ANTIULCER ACTIVITY OF  SIDDHA FORMULATION APPALAKARA 
CHOORANAM 
TABLE NO - 1 
Group Treatment 
Dose  
mg/kg 
Total 
volume 
of gastric 
secretion 
(ml/100 
gm) 
Total  
acidity 
(meq/l/ 
100g) 
PH 
Ulcer 
score 
% 
prote 
-ction 
I Normal 
control 
1 ml of 
1%cmc 
3.8±       
0.60 
422.50±   
21.55 
2.1± 
0.18 
0.28± 
0.01 
0.000 
II Ulcer 
control 
200mg/kg 
ASA 
5.4±     
0.80*a 
492.52±
*a
  24.20 
1.3±*a   
0.18 
2.1±*a   
0.15 
0.000 
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III Standard 
control 
2mg/kg 
omeprazole 
2.6±       
0.28 
328.80±    
15.20 
4.2±  
0.56 
0.52± 
0.05 
75.23 
IV Treatment 
control 
Appalakara 
chooranam 
100mg/kg  
3.1±     
0.30*b 
380.5±*b       
18.25 
3.1±*b  
0.30 
0.82±
*b
  
0.09 
60.95 
V Treatment 
control 
Appalakara 
chooranam 
200mg/kg  
3.0±     
0.32*b 
362.5±*b       
16.00 
2.6±*b  
0.26 
0.72±
*b
  
0.10 
65.71 
 
*Values are expressed as Mean± SEM 
*a – Values are significantly different from Normal control group at P<0.01 
*b -- Values are significantly different from ulcer control group at P<0.01 
 
RESULTS 
Administration of 200 mg/kg ASA suspension intragastrically consistently 
caused hemorrhagic lesions in the mucosa of the glandular stomach, indicating true 
ulcer formation as stated in histological findings. Pretreatment of rats with siddha 
formulation Appalakara chooranam through orally  at 100 and 200mg/kg prevented 
gastric ulcerogenesis significantly. But it’s seemed to be less efficient than standard 
drug like omeprazole. 
 
4.1.4.(a). Acute toxicity study of Appalakara chooranam 
 The acute toxicity of Appalakara chooranamwas evaluated using OECD- 423 
guidelines. There was no mortality or morbidity observed in animals through the 15-
days period following single oral administration at all selected dose levels of the 
Appalakara chooranam(Table-1). The animals did not show any changes in the 
general appearance during the observation period. Morphological characteristics such 
as fur, skin, eyes and nose appeared normal. No tremors, convulsion, salivation, 
diarrhea, lethargy or unusual behaviors such as self mutilation, walking backward and 
so forth were observed.  Gait and posture, reactivity to handling or sensory stimuli, 
grip strength was also normal.  
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Table.1 
Groups Dose (mg.kg-1) Sign of Toxicity (ST.NB-1) Mortality (D.S
-1) 
Group I 0 0/3 0/3 
Group II 300 0/3 0/3 
Group III 2000 0/3 0/3 
 
 
Table.1. Acute toxicity study of Appalakara chooranamon experimental mice. 
The acute toxicity of Appalakara chooranamon experimental mice was tested using 
OECD-423 guidelines, where ST- sign of toxicity; NB- normal behaviour; D- died; S- 
survive.  Values are expressed as number of animals (n=3). 
 
4.1.4(b).Effect of Appalakara chooranam in Sub acuteToxicity  
Appalakara chooranamwere evaluated for sub acute toxicity. 
 
Effect of Appalakara chooranamon body weight changes in rats 
The effect of Appalakara chooranamwas observed for their effect on the body 
weight changes from the study it was observed that, there was significant increase 
(p<0.05) in body weight in all the animals observed.   The results are shown in 
Table.2. 
 
Table.2 
Treatment Day 1 Day 5 Day 10 Day 20 
Control 180.15±6.8 191.45  ±6.20 199.15 ±6.35 199.7±6.58 
Appalakara chooranam 
50 mg.kg-1 
187.30 ±6.4 196.30  ±6.30 201.25 ±6.70 201.30±6.72* 
Appalakara chooranam 
100 mg.kg-1 
179.35 ±5.7 192.30  ±6.40 199.55  ±7.10 200.36±6.30* 
Appalakara chooranam 
200 mg.kg-1 
188.30  ±7.2 200.15±6.50 201.90  ±7.20** 209.45±7.26** 
Appalakara chooranam 
400 mg.kg-1 
180.65  ±6.05 195.15 ±5.60 198.60  ±6.35** 300.66±7.38** 
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Table.2.The effects of Appalakara chooranamon body weight changes in rats.   
A study on the effects of Appalakara chooranamon body weight changes in rats was 
carried out.. where, group I animals (GPI) were treated with normal saline (5 ml.kg-1), 
group II animals (GPII) with 50 mg.kg-1 of Appalakara chooranam,  group III 
animals (GPIII)  with 100 mg.kg-1 of Appalakara chooranam, group IV animals 
(GPIV)  with 200 mg.kg-1 of Appalakara chooranam, group V animals (GPV)  with 
400 mg.kg-1 Appalakara chooranam. The values are expressed as mean ± S.E.M. 
n=6. The results of group I were compared with other groups such as II, III, IV, and 
V.   The statistical analysis was carried out using one way ANOVA method, where 
**P<0.01 *P<0.05. 
 
Effect of Appalakara chooranamon kidney, heart, liver and brain in rats  
The effects of Appalakara chooranamon kidney, heart, liver and brain of the 
rats were observed.    From the study it was clear that, significant (p<0.01) changes in 
the weights of various organs of the animals occurred with higher doses of the extract 
(400 mg.kg-1 bwt), but macroscopic examinations did not show any changes in colour 
of the organs of the treated animals compared with the control.   The results are 
shown in Table.3. 
Table.3 
  Treatment Heart (gms) Kidney (gms) Liver (gms) Brain (gms)   
Control 0.32 ± 0.05 0.66± 0.03 3.35± 0.05 0.70± 0.05 
Appalakara 
chooranam@50    
mg.kg-1 
0.33± 0.02 0.82± 0.03 3.47± 0.03 0.73± 0.3 
Appalakara 
chooranam@100  
mg.kg-1 
0.34± 0.06 0.80± 0.04 3.39±0.02 0.71± 0.2 
Appalakara 
chooranam@                   
200 mg.kg-1 
0.33± 0.04 0.75± 0.02 3.37± 0.02 0.78± 0.05 
Appalakara 
chooranam@400  
mg.kg-1 
0.32± 0.03 0.76± 0.03 3.40± 0.03 0.80± 0.05 
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Table.3.The effects of Appalakara chooranamon kidney, heart, liver and 
brain of the rats. A study on the effects of Appalakara chooranamon kidney, heart, 
liver and brain of the rats was tested. where, group I animals (GPI) treated with 
normal saline (5 ml.kg-1), group II animals (GPII)  with 50 mg.kg-1 of Appalakara 
chooranam,  group III animals (GPIII) with 100 mg.kg-1 of Appalakara chooranam, 
group IV animals (GPIV) with 200 mg.kg-1 of Appalakara chooranam, group V 
animals (GPV)  with 400 mg.kg-1 Appalakara chooranam.  The values are expressed 
as mean ± S.E.M. n=6.   The results of group I were compared with other groups such 
as II, III, IV,  and V.  The statistical analysis was carried out using one way ANOVA 
method, where **P<0.01. 
 
Effect of Appalakara chooranamon biochemical profiles of rats   
The effect of Appalakara chooranamon various biochemical parameters of 
the experimental animal ‘rats’ were tested.  From the study it was evident that, there 
was significant decrease (p<0.05) in the plasma glucose level in treated rats especially 
at higher dose (400 mg.kg-1) compared with control rats.   The control rats were 
administered only with 5 ml of normal saline.   Significant decrease (p<0.05) in the 
plasma total cholesterol (TC), triglyceride (TG) and LDL-cholesterol levels were 
observed.   But a significant increase (p<0.05) in HDL-cholesterol levels were 
observed in all the treated animals compared with the control animals. AST, ALT and 
ALP levels were also normal in the Appalakara chooranamtreated animals. From the 
results of biochemical study there was no evidence of severe toxicity associated with 
the administration of higher concentration of Appalakara chooranam. The results are 
shown in Table.4. 
Table.4 
Treatment 
Glucose 
(mg.dl-1) 
Cholesterol 
(mg.dl-1) 
Triglyceride 
(mg.dl-1) 
HDL 
(mg.dl-1) 
LDL 
(mg.dl-1) 
Control 90.65± 0.62 39.62± 0.56 28.25± 0.45 139.25± 0.55 83.15±1.72 
Appalakara 
chooranam  
@50 mg.kg-1 
88.50± 0.56 25.85± 0.25* 13.22± 0.23* 179.28± 0.65* 70.59±1.28 
Appalakara 
chooranam 
@100 mg.kg-1 
85.45± 0.47 26.74± 0.26* 15.42± 0.28* 169.18±0.78* 68.84±1.10 
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Appalakara 
chooranam  
@200 mg.kg-1 
86.25± 0.55** 33.18± 0.30 17.84± 0.38* 188.30± 0.84* 47.60±1.30 
Appalakara 
chooranam 
@400 mg.kg-1 
82.25± 0.45** 32.78± 0.28 19.28± 0.34* 186.2± 0.85* 45.50±0.84 
 
Table.4.The effect of Appalakara chooranamon biochemical parameters such 
as glucose, cholesterol, triglyceride, HDL and LDL. A study on the  effect of 
Appalakara chooranamon biochemical parameters such as glucose, cholesterol, 
triglyceride, HDL and LDL in rats was tested.where, group I animals (GPI) treated 
with normal saline (5 ml.kg-1), group II animals (GPII)  with 50 mg.kg-1 of 
Appalakara chooranam,  group III animals (GPIII)  with 100 mg.kg-1 of Appalakara 
chooranam, group IV animals (GPIV)  with 200 mg.kg-1 of, group V animals (GPV)   
with 400 mg.kg-1 Appalakara chooranam. The values are expressed as mean ± 
S.E.M. n=6.   The results of group I were compared with other groups such as II, III, 
IV, and V.  The statistical analysis was carried out using one way ANOVA method, 
where **P<0.01 *P<0.05 
 
Table.5 
 
Treatment 
AST 
(IU.l-1) 
ALT 
(IU.l-1) 
ALP 
(IU.l-1) 
TP 
(g.l-1) 
ALBUMIN 
(g.l-1) 
Control 321.5±12.40 74.5± 3.18 256.58± 8.80 72.85± 3.32 40.15±2.35 
Appalakara 
chooranam 
@50 mg.kg-1 
310.0±9.50** 72.5± 2.20** 269.10± 2.75** 73.30± 2.32 37.30±2.65 
Appalakara 
chooranam 
@100 mg.kg-1 
311.3±7.20** 70.1± 3.15** 263.18± 6.70** 83.15± 2.82 39.30±3.05 
Appalakara 
chooranam 
@200 mg.kg-1 
306.4±7.95 65.4± 2.90 268.00± 5.20 72.25± 3.32 41.20±2.75 
Appalakara 
chooranam 
@400 mg.kg-1 
316.2± 8.20 67.3± 3.52 272.40± 4.40 77.05± 2.58 40.48±2.70 
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Table.5.The effects of Appalakara chooranamon biochemical parameters 
such as AST, ALT, ALP, TP and Albumin in rats. A study on the effects of 
Appalakara chooranamon biochemical parameters such as AST, ALT, ALP, TP and 
Albumin rats was tested. where, group I animals (GPI)  were treated with normal 
saline (5ml.kg-1),  group II animals (GPII) with 50 mg.kg-1 of HAEBD group III 
animals (GPIII)  with 100 mg.kg-1 of Appalakara chooranam, group IV animals 
(GPIV)  with 200 mg.kg-1 of Appalakara chooranam,  and group V animals (GPV)  
with 400 mg.kg-1 Appalakara chooranam The values are expressed as mean ± S.E.M. 
n=6.   The results of group I were compared with other groups such as II, III, IV, and 
V.   The statistical analysis was carried out using one way ANOVA method, where 
**P<0.01 *P<0.05. 
 
Effect of Appalakara chooranam on haematological parameters in rats   
The effects of Appalakara chooranam were observed for its effect on 
haematological parameters on the experimental rats. From the study it was evident 
that, a significant increase (p<0.01) were observed in the haemoglobin contents and  
RBC count  in the group treated with 200 mg.kg-1 body weight of Appalakara 
chooranam and a significant decrease of the parameters occurred in the group treated 
with 400 mg.kg-1 b.w.t compared with the control.   There was no significant change 
in the calcium level in all the treated animals compared to the control. 
 
Table.6 
Treatment 
Haemoglobin 
(mg.dl-1) 
RBC 
(106 /mm3) 
WBC 
(106 /mm3) 
Calcium 
(mg.dl-1) 
Control 14.3± 0.25 9.15± 0.02 11.9± 0.05 10.40 ±0.06 
Appalakara 
chooranam 
@50 mg.kg-1 
15.5± 0.26* 9.50± 0.04* 10.05± 0.01* 10.16 ±0.07 
Appalakara 
chooranam 
@100 mg.kg-1 
15.3± 0.15* 9.55± 0.02* 8.8± 0.32* 10.22 ±0.24 
Appalakara 
chooranam 
@200 mg.kg-1 
13.7± 0.20* 8.33± 0.12* 11.9± 0.03* 10.56 ±0.12 
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Appalakara 
chooranam 
@400 mg.kg-1 
14.5± 0.35* 8.51± 0.45* 11.05± 0.13* 10.70 ±0.06 
 
Table.6.The effect of Appalakara chooranam on haematological parameters 
such as HB, Calcium, RBC and WBC in rats. A study on the effect of Appalakara 
chooranam on haematological parameters such as Hb, RBC, WBC, Calcium in rats 
was tested. where, group I animals (GPI) treated with normal saline (5 ml.kg1), group 
II animals (GPII)  with 50 mg.kg-1 of Appalakara chooranam,  group III animals 
(GPIII)   with 100 mg.kg-1 of Appalakara chooranam,   group IV animals (GPIV)   
with 200 mg.kg-1 of Appalakara chooranam, and  group V animals (GPV)  with 400 
mg.kg-1 Appalakara chooranam. The values are expressed as mean ± S.E.M. n=6. 
The results of group I were compared with other groups such as II, III, IV and V.   
The statistical analysis was carried out using one way ANOVA method, where 
*P<0.05. 
 
Discussion 
The evaluation of acute and sub-acute dosing in experimental animals may be 
more relevant in determining the overall toxicity of the plant preparation.  The highest 
overall concordance of toxicity in animals in comparison with humans is with 
hematological, gastrointestinal, and cardiovascular adverse effects whiles certain 
adverse effects in humans, especially hypersensitivity and idiosyncratic reactions, are 
poorly correlated with toxicity observed in animals . 
  
In the present study, where the acute toxicity study of Appalakara chooranam 
was carried out as per OECD-423 guidelines, no mortality was observed in both the 
animals of control group as well as animals treated with a maximum dose of 2000 
mg.kg-1.   Hence, 1/10th of 2000 mg.kg-1 i.e. 200 mg.kg-1 of dose was selected as a 
minimum dose for sub-acute toxicity study. 
The results of sub-acute toxicity study shows that there was no significant 
change in animal behaviour due to the absence of toxicity.   The animals treated with 
Appalakara chooranam showed normal growth pattern and body weight compared 
with control rats treated with normal saline. So the changes in body weight can be 
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used as an indicator of adverse effects of drugs and chemicals .The changes in 
enzymes like ALP, AST and ALT levels show liver impairment, due to toxicity 
Serum cholesterol and proteins mainly regulated via synthesis in the liver and increase 
or decrease in serum concentrations of constituents suggest liver toxicity.   The results 
of the present study were assessed after 28 days of administration of Appalakara 
chooranam, and it was found that Appalakara chooranam at all concentrations do 
not produce liver damage. 
 
There was a slight decrease in plasma glucose level, when higher doses of 
Appalakara chooranam(400 mg.kg-1) were administered in the treated rats..  
 
Analysis of blood parameters is likely to risk evaluation as the change in 
hematological system has a higher predictive value for human toxicity, when data are 
translated from animal studies (Olson, et al., 2000).(7)   After 28 days of treatment, 
there were no significant changes in the haematological parameters between control 
and treated groups.   No significant changes in the levels of WBC, RBC were 
observed between control and test groups following repeated administration of 
Appalakara chooranam. Interestingly, significant increase in the levels of 
hemoglobin was found in treatment with  Appalakara chooranam with a higher dose 
of  400 mg.kg-1. The possible reason could be that one of the constituents  
Appalakara chooranam may increase absorption of iron.  
 
The overall results suggest that Appalakara chooranam are non toxic to the 
haaematopoietic and leucopoietic system.   The haematopoietic and leucopoietic 
systems are the most sensitive targets for toxic compounds and an important index of 
physiological and pathological status in man and animal .  Therefore, it is possible to 
assume that the Appalakara chooranam is non haematotoxic. 
 
 
 
4.1.5: FTIR and EDAX ANALYSIS 
4.1.5.a. Scanning electron microscopic study (SEM)  
Scanning electron microscopy is a complementary technique and shows the 
nature of Appalakarachooranam and its particle size.Sample for SEM analysis were 
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mounted on the specimen stub using carbon adhesive sheet. Small sample were 
mounted with 1sq. cm glass slide And kept in carbon adhesive sheet (Yashvanth.S et 
al 2013) Samples were coated with gold to a thickness of 100 AO using Hitachi 
vacuum evaporator. Coated sample were analyzed in a Hitachi Scanning electron 
Microscope 3000 H model. Then the electronic image was captured and noted. 
 
Elemental analysis by EDAX  
EDAX is a non destructive technique and can be used for evaluvation in 
physiochemical properties of Applakara Choornam. This is very useful for the 
characterize crystalsof traceelements inAppalakaraChooranam (AKC). The Small 
pieces of salt of (3-4 mm) and 5-6mm2 pieces of salt were fixed in 4% glutraldehyde 
in phosphate buffer (Viz PH value 0.02 M, 6.9 M respectively). The sample was air 
dried and coated with gold in Hitachi HUS-5 GB Vacuum evaporator. SEM-EDAX 
analysis was carried out using INCA X-sight Oxford detector fitted to Hitachi S-520 
Scanning Electron Microscope at an acceleration voltage of 20 KV.  
 
4.1.5.b Fourier Transform – Infra Red Spectroscopy Study (FTIR)  
IR data acquired with Spectrum one FT-IR Spectrometer by means of KBr 
Pellet was used,. about 1/8th of the solid powder of Appalakarachooranam was taken 
on a microspatula and about 0.25-0.50 teaspoons of KBr was added and thoroughly 
ground in an agate mortar with the pestle until AKC.The sample was pressed at 5000-
10,000 psi and the sample was removed carefully from the die and placed in the FTIR 
sample holder  The sample was placed on Zn,Sel crystal with a spatula until the 
pressure marker noted.  
 
Results and Discussion  
The results of Scanning electron microscope in two different view and EDAX 
Trace elements profile & FT-IR data has compiled as follows. 
 
4.1.5.c Scanning Electron Microscope Analysis  (SEM) 
The SEM (Fig.No.1 a) under 1.00 KX resolutions and the examining area of 
800x800µm and 2 surface were taken. The surface of the AKC grains is uniformly 
arranged in agglomerates. Particle Size of the desired drug particle ranges from 3µm 
to 1613 µm in 2 µm (Figure 1 b). 
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                                Fig.No.1a Fig.No.1b 
 
 
In 100mu view, the surface of the sample grains is uniformly agglomerates. Particle 
Size ranges from Particle Size of the desired drug particle ranges from 296µm to 2792 
µm. 
(Figure. 2 a &b) SEM image and plotting diagram of Appalakarachooranam in 20µm 
 
 
 
 
 
 
 
4.1.5.d. Elemental Quantification of Appalakarachooranam by EDAX  
The elemental quantification of Appalakarachooranam was carried by the 
SEM-EDAX methods.The overall trace elements like Sodium,potassium, Chlorine 
and oxygen viz35.59%, 30.29%, 18.07, 30.29% respectively. The sample was placed 
on Zn, Sel crystal with a spatula until the pressure marker noted. Results and 
Discussion The results of Scanning electron microscope in two different view and 
EDAX Trace elements profile & FT-IR data has compiled as follows. Scanning 
Electron Microscope Analysis The SEM (Fig.No.1 a) under 1.00 KX resolutions and 
the examining area of 800x800µm and 2 surface were taken. The surface of the AKC 
grains is uniformly arranged in agglomerates. Particle Size of the desired drug particle 
ranges from 3µm to 1613 µm in 2 µm (Figure 1 b). In FT-IR Spectra analysis, the 
values are recorded in table no 1.The peak value is 3462.22 to 3695.61 onO-H 
stretching, 2520.96 has C-H stretching, 2380.16 has N-H stretching, 2254.79 has - 
C≡Nstretching, 2108.20 has N=C=S stretching, 1635.64 has C=C stretching, 1460.11 
has C-H bending, 1336.67 has O-H bending. Thus the corresponding peak valuehas 
    Fig.No.2a     Fig.No.2b  
separate functional groups viz Alcohol, Alkene, Amine salt, nitr
Alkenes, and Phenolic compound etc.
Identification of trance elements through EDAX
 
Graphical representation of EDAX Profile
FTIR Spectra of AppalakaraChooranam
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ates, Isothyiocyante, 
 
 
 
Fig. No. 3 
 
Fig. No 4 
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Fig. No 5 
 
Table 1.FTIR observed Peak value ofAppalakarachooranam 
Wave 
number 
(cm-1) 
Intensity of the 
bond 
Functional 
groups 
 
3695.61 O-H stretching variable alcohol 
3462.22 O-H stretching Variable 
intermolecular 
bonded 
2520.96 C-H streching Medium Alkene 
2380.16 N-H stretching Strong amine salt 
2254.79 -C≡Nstretching Weak nitrile 
2108.20 N=C=S stretching Strong Isothiocyanate 
1635.64 C=C stretching Medium Alkene 
1460.11 C-H bending Medium Alkane 
1336.67 O-H bending medium Phenolic compound 
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916.19 C=C bending Strong Alkene 
877.61 aromatic C-H bending medium Alkane 
850.61 C-Cl stretching Strong halo compound 
615.29 C-Br stretching Strong 
halo compound 
 (alkyl) 
538.14 C-Br bending Week Alkyl 
 
In FT-IR Spectra analysis, the values are recorded in table no 1.The  peak 
value is 3462.22 to 3695.61 onO-H stretching, 2520.96 has C-H stretching, 2380.16 
has N-H stretching, 2254.79 has -C≡Nstretching, 2108.20 has N=C=S stretching, 
1635.64 has C=C stretching, 1460.11 has C-H bending, 1336.67 has  O-H bending. 
Thus the corresponding peak valuehas separate functional groups viz Alcohol, 
Alkene, Amine salt, nitrates, Isothyiocyante, Alkenes, and Phenolic compound etc.  
 
Conclusion 
In Siddha System of medicine is bioeffective and safe therapeutic potentials of 
AKC. On the line, the drug Appalakarachooranam lies on the track and the above data 
showed that the spectroscopic standardization of the AKC. Final conclusion is FTIR, 
EDAX and SEM analytical studies showed no harmful chemicals and minerals 
etc.so,applakarrachoornam is safe to use in long period. Thefurther research works 
has to be carried out for the development of scientific data to hold the drug in a 
scientific manner.  
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4.1.6   BIO-CHEMICAL ANALYSIS OF APPALAKARA  
CHOORANAM PREPARATION OF THE EXTRACT 
The extract is directly prepared from the trial drug Appalakara Chooranam. 
QUALITATIVE ANALYSIS 
 
Sl. 
No. EXPERIMENT OBSERVATION INFERENCE 
1. TEST FOR CALCIUM 
2ml of the above prepared extract is taken in 
a clean test tube.  To this add 2ml of 4% 
Ammonium oxalate solution. 
No white 
precipitate is 
formed. 
Absence of 
calcium. 
2. TEST FOR SULPHATE: 
2ml of the extract is added to 5% Barium 
chloride solution. 
A  white 
precipitate is 
formed 
Indicates the 
presence of 
Sulphate. 
3. TEST FOR CHLORIDE 
The extract is treated with Silver nitrate 
solution. 
A white 
precipitate is 
formed. 
Indicates the 
presence  of 
chloride. 
4. TEST FOR CARBONATE 
The substance is treated with concentrated 
Hcl. 
brisk 
effervescence is 
formed. 
Indicates the 
presence of 
Carbonate. 
5. TEST FOR STARCH 
The extract is added with weak Iodine 
solution. 
No blue colour is 
formed. 
Absence of 
Starch. 
6 TEST FOR IRON FERRIC 
The extract is acidified with Glacial acetic 
acid and Potassium ferro cyanide. 
No blue colour is 
formed. 
Absence of 
ferric Iron 
7. TEST OF IRON FERROUS 
The extract is treated with concentrated Nitric 
acid and Ammonium thio cynaate solution. 
 Blood  red colour 
is formed. 
Indicates the 
presence of 
ferrous Iron.  
8. TEST FOR PHOSPHATE 
The extract is treated with Ammonium 
molybdate and concentrated Nitric acid. 
No yellow 
precipitate is 
formed. 
Absence of 
phosphate.  
9. TEST FOR ALBUMIN 
The extract is treated with Esbach’s reagent. 
No yellow 
precipitate is 
formed. 
Absence of 
albumin. 
10. TEST FOR TANNIC ACID 
The extract is treated with Ferric choloride. 
No blue black 
precipitate is 
formed. 
Absence  of 
tannic acid. 
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Sl. 
No. EXPERIMENT OBSERVATION INFERENCE 
11. TEST FOR UNSATURATION 
Potassium permanganate solution is added to 
the extract. 
It gets 
decolourised. 
Indicates the 
presence of 
unsaturated 
compound. 
12. TEST FOR THE REDUCING SUGAR 
5ml of Benedict’s qualitative solution is 
taken in a test tube and allowed to boil for 2 
mts and added 8-10 drops of the extract and 
again boil it for 2 mts. 
No colour change 
occurs. 
Absence  of 
reducing sugar. 
13. TEST FOR AMINO ACID 
One or two drops of the extract is placed on a 
filter paper and dried it well. After drying, 
1% Ninnydrin is sprayed over the same and 
dried it well. 
No violet colour is 
formed. 
Absence  of 
amino acid. 
14. TEST FOR ZINC: 
The extract is treated with Potassium 
Ferrocyanide. 
No white 
precipitate is 
formed. 
Absence of 
Zinc. 
 
 
INFERENCE: Calcium, Sulphate, chloride, Carbonate, ferrous Iron and  unsaturated 
compound are present in the trial drug Appalakara Chooranam. 
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4.1.7  ANTIMICROBIAL  RESULTS 
       
Sample Code 
Bacteria  Strains Name 
Staphy
lococc
us 
aureus 
(G+) 
Streptococc
us mutans 
(G+) 
 
Bacillus 
subtilis (G+) 
 
 
Klebsilla 
pneumonia 
(G-) 
E – coli 
(G-) 
AC 7 11 8 10 10 
PC 27            17 14 28 18 
NC - - - - - 
 
Keys 
             PC         -     Positive Control (Streptomycin) 
NC                          -    Negative Control 
 -                              -    No Zone 
Mm                        -    Millimetre  
           G+                          -   Gram Positive Organism 
            G-                           -   Gram Negative Organism 
                                
  
The medium was prepared by dissolving 38 gram of Muller Hinton Agar Medium (HI 
media) in 1000 milli litre of distilled water .. The dissolved medium was autoclaved at 
15Lbs pressure at 121o C for 15 min (pH 7.3) the autoclaved medium was cooled 
,mixed well and poured petriplates (25ml/plate )the plates were swabbed with 
pathogenic bacteria culture viz. 
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ANTIMICROBIAL  RESULTS FIGURES 
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4.2 CLINICAL STUDY 
OBSERVATIONS AND RESULT 
 The  clinical study 40  patients  were selected, 20 patients in OPD and 
remaining 20 patients were  treated in IPD at PG Department of Pothu Maruthuvam, 
G.S.M.C Palayamkottai. Results were documented in following the headings, 
1. Sex  
2. Age  
3. Kaalam  
4. Constitution of the Body  
5. Gunam  
6. Religion  
7. Thinai  
8. Paruvakaalam  
9. Occupational status  
10. Diet  
11. Socio-Economic status  
12. Aetiological factors  
13. Mode of onset  
14. Duration of illness  
15. Clinical manifestation  
16. Gnanendrium  
17. Kanmendrium  
18. Conditions of Mukkutram :  
i) Vatham  
ii) Pitham 
iii) Kapham  
iv) Thontham  
19. Udal thathukkal  
20. Envagai Thervugal  
21. Neikuri 
22. Assessment of outcome  
a) Before treatment  
b) After treatment  
23. Radiological findings   
24. Gradation of Results  
1)  SEX  
Table 1: sex distribution
S.No Sex 
1. Male 
2. Female 
 
Figure 1: sex distribution
Inference :  
20 out patients, 60% were male and 40%
65% were male and 35% 
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females were affected  
No of cases in IP 
12 13
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  2) AGE  
Table 2 :Age  distribution
 
S.No 
Age group 
in year  
1. 30-40 
2. 41-50 
3 51-60 
 
Figur 2: Age  distribution
Inference:   
20 out patients  were  selected,   10%
40 years, 30% were  affected  in 41
patients .20 In  patients  were  selected ,10%
40 years, 25% were  affected  in 41
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  people were affected in age  group 30
-50 years ,60% were affected  in 
  people were affected in age  group 30
-50 years ,65% were affected  in  51-60years.  
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3) KAALAM 
Table 3 : Kaalam distribution
S.No Kaalam 
1. Vatha Kaalam  
(First 33 yrs and 4 months)
2. Pitha Kaalam  
(Second 33 yrs and 4 
3. Kapha Kaalam 
(Third 33 yrs and 4 months)
 
Figure : 3 Kaalam distribution
Inference :  
20 out patients  were
under pitha kaalam.  20 In patients
95% comes under pitha kalam
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  selected  10% comes under Vatha kaalam, 90% comes 
  were  selected  5% comes under Vatha kaalam, 
 
Pitha Kaalam 
(Second 33 yrs 
and 4 months)
Kapha 
Kaalam(Third 
33 yrs and 4 
months) 
No of cases in OP
No of cases in IP
 
 % 
5 
95 
0 
 
4) CONSTITUTION OF THE BODY :
Table 4: Constitution of the body  distribution
S.No Constitution of the body
1. Vatha pitham 
2. Vatha kapham 
3. Piththa vatham 
4. Piththa kapham
                         
 
Figure :4: Constitution of the body distribution
Inference :  
  20 out patients were selected, 55% were affected in vatha piththa thegi, 25% 
were affected in  vatha  kapha  thegi, 15% were affected in  piththa vatha thegi,5%  
were afeced  in piththa kapha thegi. 
 20 In patients were selected,45 % were affected in vat
were affected in  vatha  kapha  thegi, 15% were affected in  piththa vatha thegi,5%  
were afeced  in piththa kapha thegi. 
.  
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Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
11 55 9 
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5) GUNAM  
Table 5: Gunam distribution
S.No Gunam
1. Sathuvagunam 
2. Rajogunam  
3. Thamogunam  
 
 
Figure :5 Gunam distribution
 
Inference :  
  20 out patients were selected,
affected in Sathuvagunam , 20
20 In patients were selected,
affected in Sathuvagunam ,25 
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Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
 5 25 3 
11 55 12 
4 20 5 
 
 55% were affected in Rajogunam
% were affected in  Thamogunam.   
 60% were affected in Rajogunam, 15
% were affected in  Thamogunam. 
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6) RELIGION  
Table: 6 Religion distribution
S.No Religion
1. Hindu 
2. Christian 
3. Muslim 
 
 
Figure:6 Religion distribution
 
Inference :  
20 out patients were selected,
Christian  people were affected
  20 In patients were selected,
affected in Christian  people ,5 % 
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Out Patients (OP) Inpatients 
No of cases % 
No of 
cases 
19 95 18 
1 5 1 
0 0 1 
 
 95% were affected in Hindu people, 
 .   
 90% were affected in Hindu people ,5
 Muslim  people were affected. 
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5%  
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7) THINAI  
Table :7 Thinai distribution
S.No Thinai
1. Kurinji 
2. Mullai  
3. Marutham 
4. Neithal 
5. Palai 
 
Figure : 7 Thinai distribution
Inference :  
20 out patients were selected,
in  Marutham, 80% were affected in 
 20 In patients were selected
in  Marutham, 70% were affected in 
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Out Patients (OP) Inpatients (IP)
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No of 
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 15% were affected in Mullai, 5% were affected 
 Neithal land. 
 , 20% were affected in Mullai, 10% were affected 
 Neithal land. 
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% 
0 
20 
10 
70 
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8) PARUVA KALAM    
Table 8:  Paruva kalam distribution  
S.No Paruvakalam Months  
Out Patients 
(OP) 
Inpatients 
(IP) 
No of 
cases 
% 
No of 
cases 
% 
1. Kar Kalam Aavani- Puratasi 9 45 11 55 
2. Koothir Kalam Iyppasi - Karthigai  3 15 4 20 
3. Munpani kalam Markazhi – Thai 1 5 2 10 
4. Pinpani kaalam Masi- Panguni 0 0 0 0 
5. Elavenil Kaalam Chithirai - Vaikasi  3 15 1 5 
6. Muthuvenil kaalam Aani- Aadi 4 20 2 10 
 
Figure : 8 Paruva kalam distribution 
out patients
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Inference :  
 20 out patients were selected, 45% were affected in Kaar kaalam, 15% were 
affected in  Koothir kaalam, 5% were affected in  Munpani kaalam,15%  were 
affected  in Elavenil kaalam,20%  were affected in Muthuvenil kaalam. 
20 In  patients were selected, 55% were affected in Kaar kaalam, 20% were 
affected in  Koothir kaalam, 10% were affected in  Munpani kaalam,5%  were affeced  
in Elavenil kaalam,10%  were affected in Muthuvenil kaalam.  
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9) Occupation  :  
Table 9: Occupation distribution 
S.No Occupation 
Out Patients (OP) Inpatients (IP) 
No of cases % No of cases % 
1. Agricultural labour 3 15 5 25 
2. Beedi worker 2 10 2 10 
3. House wife 4 20 4 20 
4. Teacher  0 0 1 5 
5. Clerk 4 20 1 5 
6. Cotton mills 0 0 2 10 
7. Weight lifter 1 5 3 15 
8. Tailor 2 10 1 5 
9. Driver 4 20 0 0 
10. Mesan 0 0 1 5 
                
Figure 9: Occupation  distribution 
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Inference :  
20 out patients were selected, 15% were affected in  agricultural  labour, 10% 
were affected in  beedi worker, 20% were affected in house wife,20%  were affected  
in clerk,5%  were affected in weight lifter,10% were affected in tailor,20% driver 
were affected.  
20 in patients were selected, 25% were affected in agricultural labour, 10% 
were affected in  beedi worker, 20% were affected in house wife, 5% were affected in 
teacher, 5%  were affect
affected in weight lifter,5% were affected in tailor,5% 
 
10) DIET : 
Table 10:Diet Distribution
S.No Diet
1. Vegetarian 
2. Non –Vegetarian
 
Figure 10: Diet Distribution
 
 
Inference :  
20 out patients were selected,
were affected in  mixed vegetarian people.
affected in vegetarian people, 70
 
 
 
0
Vegetarian
Non -Vegetarian
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ed  in clerk,10% were affected in cotton mill, 15%  were 
mesan were affected.
 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
5 25 6 
 15 75 14 
 
 25% were affected in vegetarian people , 75
 20 in patients were selected,
% were affected in mixed vegetarian.  
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11) SOCIO- ECONOMIC STATUS 
Table : 11 Socio- Economic status 
S.No Socio- Economic Status 
1. High income group
2. Middle  Income group
3. Low Income group 
      
      Figure 11: : Socio- Economic status 
 
Inference :  
 70% of cases mostly  affected in Low
cases were in affected in  M
affected.  
 85% of cases were
were affected in  Middle income group
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distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
 0 0 0 
 6 30 3 
 14 70 17 
 
 income people and remaining 
iddle income group.  High income peoples are not 
 affected in Low income people and remaining 
. High income peoples are not affected.
Middle  Income 
group
Low Income 
group 
 
% 
0 
15 
85 
 
30% 
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12) ETIOLOGICAL  FACTORS : 
Table 12: .Etiological factors
S.No Aetiological factors  
1. Age  
2. Occupation 
3. Trauma 
4. Congenital abnormalities 
 
Figure12. Etiological factors
 
Inference :  
 The mode of etiological factors of cegana vatham
affected in age related  degenerative disease in OPD. 35
occupational  disorders  and  65% of the cases   were  affect
degenerative disease in IPD. 
Age 
Occupation
Trauma
Congenital abnormalities 
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 distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
9 45 13 
11 55 7 
0 0 0 
 0 0 0 
 distribution 
   was  45% 
% of cases were 
ed in age related  
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 13).MODE OF ONSET 
Table 13: Mode of onset distribution
S.No Mode of onset 
1. Acute 
2. Chronic 
 
 
Figure13: Mode of onset distribution
Inference 
The chronic  onset of the 
both OPD  and IPD. 
0 20
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Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
0 0 0 
20 100 20 
  
 
 
cegana vatham   was  100%  people were affected in 
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14) DURATION OF ILLNESS  
Table14: Duration of illness distrbution 
S.No Duration of illness  
Out Patients (OP) Inpatients (IP) 
No of cases % 
No of 
cases 
% 
1. 15-30 days  2 10 1 5 
2. 1-3 months  6 30 2 10 
3. 3-6 months 3 15 5 25 
4. 6-12 months 2 10 4 20 
5. > 12 months 7 35 8 40 
 
Figure 14:. Duration of illness distrbution 
 
 
 
Inference :  
  Duration of illness was  35% in > 12 months, 30% in 1-3 months, 15% in 3-6 
months, 10% in 6-12 months and 10% in 15-30 days were affected in OPD. The 
duration of illness was  10% in 1-3 months, 25% in 3-6 months, 20% in 6-12 months, 
40% in >12 months, 5% in 15-30 days were affected in IPD.  
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15) CLINICAL MANIFESTATION  
Table 15: Clinical manifestation distribution 
S.No Signs and symptoms  
Out Patients (OP) Inpatients (IP)S 
No of cases % No of cases % 
1. Pain in the neck 20 100 20 100 
2. Restricted  movement in the neck 18 80 14 70 
3. Radiating pain in upper limbs  20 100 210 100 
4. Headache 8 40 13 65 
5. Numbness 12 60 8 40 
6. Constipation 4 20 5 25 
7. Giddiness 3 15 7 35 
8. Burning sensation of eyes 6 30 4 20 
9. Tingling sensation 0 0 0 0 
10. Feeling of heaviness of the body  2 10 5 25 
11. Weakness of upper limbs 3 15 2 10 
12. Mental depression  1 5 3 15 
 
 
Figure 15: Clinical manifestation distribution 
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Inference :  
In OPD, 100% of the cases had  neck pain, radiating pain and  80% of the 
cases had restricted  neck movements, 60% of the cases had numbness, 40% of the 
cases had headache, 30% of the cases had burning sensation of eyes.  20% of the 
cases had constipation, 10% of the cases had feeling heaviness of the body, 15% the 
cases had weakness of the upper limbs and 5% of the cases had mental depression 
were observed in Clinical trial. 
 
In IPD, 100% of the cases had  neck pain, radiating pain and  70% of the cases 
had restricted  neck movements, 40% of the cases had numbness, 65% of the cases 
had headache, 30% of the cases had burning sensation of eyes,  25% of the cases had 
constipation, 25% of the cases had feeling heaviness of the body, 10% of the cases 
had weakness of the upper limbs and 15% of the cases had mental depression were 
observed. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
16) GNANENDRIUM  
Table 16: Gnanendrium re
 
Figure 16: Gnanendrium re
 
Inference :  
 100% peoples  were  affected  Mei.
affected.  
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5. Sevi 
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ference distssribution  
ference distssribution
 The Kan, Vai, Mooku and Sevi 
Vai Kan Mooku Sevi
0 0 0 0
0 0 0
Out Patients (OP)
Inpatients (IP)
 
Out Patients (OP) Inpatients (IP)
No of cases % No of cases
20 100 20 
0 0 0 
0 0 0 
0 0 0 
0 0 0 
 
were not 
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17) KANMENRIUM 
Table 17: Kanmendrium
S.No Kanmendrium 
1. Vaai 
2. Kaal 
3. Kai 
4. Eruvai 
5. Karuvai 
 
Figure 17. Kanmendrium
Inference :  
100% were affected in
were  affected in Kai  and  25% were affected   Eruvai  in IPD.
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 distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
0 0 0 
0 0 0 
20 100 20 
4 20 5 
0 0 0 
 distribution 
 Kai  and  20% were affected in  Eruvai. 100
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18) CONDITIONS OF MUKKUTRAM : 
Table 18 a :Disturbance of Vaatham 
S.No Disturbance of Vaatham
1. Piranan 
2. Abanan  
3. Viyanan 
4. Udhanan 
5. Samanan 
6. Naagan  
7. Koorman  
8. Kirukaran 
9. Dhevathathan  
10. Dhananjeyan 
 
Figure 18 a :Disturbance of Vaatham
 Inference :  
 Abanan was 20% 
Viyanan  and Samanan 
35% dhevathathan was affected  and 100% peoples Viyanan  and Samanan 
affected in IP.   
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distribution:  
 
Out Patients (OP) Inpatients (IP)
No of cases % No of cases
0 0 0 
4 20 5 
20 100 20 
0 0 0 
20 100 20 
0 0 0 
0 0 0 
0 0 0 
13 65 7 
0 0 0 
 distribution : 
 affected, 65% dhevathathan  was  affected  and  100% 
were affected in OP patients. 20%  Abanan was  affected, 
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Table 18 b:Disturbance of Pitham 
S.No Disturbance of Pitham
1. Analpitham 
2. Ranjagam 
3. Prasagam 
4. Alosagam 
5. Sathagam 
 
Figure 18 b:Disturbance of Pitham
 
Inference :  
25% Analpitham was  affected, 40
pitam  was affected OPD.  5
affected  and 100%  Sathaga pitham was 
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Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
5 25 3 
8 40 12 
0 0 0 
0 0 0 
20 100 20 
 distribution : 
% Ranjagm was  affected. 100% Sathaga 
% Analpitham was affected. 60% Ranjaga pitham  was 
 affected.  
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Table 18 c: Disturbance 
S.No Disturbance of Kaph
1. Avalambagam 
2. Kilethagam 
3. Pothagam 
4. Tharpagam 
5. Santhigam 
 
Figure 18 c: Distance of Kapham distribution
 
Inference :  
15% Santhigam. were affected
in OP patients. 15% tharpagam was  affected and100% Santhigam was  affected in  IP 
patients. 
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Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
0 0 0 
0 0 0 
          0          0 0 
3 15 3 
20 100 20 
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19) UDALTHATHUKKAL 
Table 19: Udalthathukkal and relative percentage
S.No Udalthathukkal 
1. Saaram 
2. Senneer 
3. Oon 
4. Kozhuppu  
5. Enbu  
6. Moolai  
7. Sukkilam/ Suronitham
 
Figure 19: Udalthathukkal 
Inference :  
30% were affected in
in  Kozhuppu,100%were affected in Enbu  and 
80 % were affected in Oon,60
Kozhuppu,100%were affected in Enbu  and 
Saaram
Senneer
Oon
Kozhuppu 
Enbu 
Moolai 
Sukkilam/ Suronitham
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 distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % No of cases
20 100 20 
8 40 12 
6 30 16 
17 85 15 
20 100 20 
0 0 0 
 0 0 0 
and relative percentage distribution 
 Oon . 40% were affected in  Senneer,85%  
 Saaram. 20 In patients were selected
% were affected in  Senneer,75%  were affected in 
 Saaram .  
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20) ENVAGAI THERVUGAL   
Table 20: Envagai Thervugal and Relative percentage distribution :  
S.No Envagai Thervugal  
Out Patients (OP) Inpatients (IP) 
No of cases % 
No of 
cases 
% 
1. Naadi (Thontha Naadi) 20 100 20 100 
2. Sparisam 10 50 12 60 
3. Naa 0 0 0 0 
4. Niram  0 0 0 0 
5. Mozhi            0 0 0 0 
6. Vizhi  0 0 0 0 
7. Malam  4 20 5 25 
8. Moothiram  0 0          6 0 
 
Figure 20: Envagai Thervugal and Relative percentage distribution :  
 
Inference :  
 50% Sparisam was affected and  20% was  affected in  malam,100%  Naadi 
was  affected in OP patients. 60 % Sparisam was affected ,25%  Malam was affected  
and  100%  Naddi  was  affected in IP patients.   
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21) NEIKURI  
Table 21: Neikuri distribution
S.No Neikuri 
1. Vatha  pitham 
2. Vatha kapham 
3. Pittha vatham 
4.  Pithakapham 
 
Figure 21: Neikuri distribution
 
 
 
Inference :  
  55% had Vatha pitham
and 5%  had piththa kapha
45 %  had Vatha piththam , 35% had  Vatha  kapham, 15% had  Piththa 
vatham and 5% had  Piththa kapham neikuri appearance
.  
0
2
4
6
8
10
12
121 
 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
11 55 9 
5 25 7 
3 15 3 
1 5          1 
 
  and  25% had Vatha  kapham, 15% had  Pith
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22) ASSESSMENT OF OUTCOME  
Table 22 a :Before treatment
S.No Pain scale  
1. Mild (40-60%) 
2. Moderate (60-80
3. Severe (80-100%)
 
 
Figure 22.a :Before treatment 
Inference :  
 Table & figure no 22a  showed, 75% was in moderate symptoms, 5% was 
affected in  severe problems and 20%  patients have mild symptoms were observed  
before  starting the treatment
 Table & figure no 22a   showed
10% having  severe symptoms, 20
starting the treatment in IP patients
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  Pain scale  distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
4 20 4 
%) 15 75 14 
 1 5 2 
 Pain scale  distribution 
 in OP patients.  
  70%  patients having  moderate sy
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Table 22.b:After treatment 
S.No Pain scale  (Improvement)
1. Good (Below 10%)
2. Moderate (10-20
3. Mild(20-35%) 
4. No improvement 
(Above 40%) 
 
Figure 22 b: After treatment Improvement Pain scale  distribution
 
Inference :  
 80% of cases had  
cases had mild  response 
75% of  cases had good response, 20
cases had mild response were observed in IP patients
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Improvement Pain scale  distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
 16 80 15 
%) 3 15 4 
1 5 1 
 0 0 0 
 
good response, 15% of cases had moderate response, 5% of 
were observed in OP patients.  
% of  cases had moderate response, 5% of 
.  
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No of cases in IP
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23) RADIOLOGICAL FINDINGS : 
Table 23: Radiological findings
S.No Radiological findings   
1. Degeneration 
2. Narrowing IVDS
3. Osteophytic changes
4. Loss of lordosis
 
Figure 23: Radiological findings distribution
 
 
 
 
 
 
 
 
 
 
 
Inference :  
Mostly 80% of op  cases
osteophytic changes and 10% of the cases had altered 
radiological investigations
of  cases had narrowing  IV
in radiological investigations
 
0
2
4
6
8
10
12
14
16
18
124 
 
 distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
16 80 17 
 0 0 1 
 2 10          2 
 2 10 0 
 
 had bony degeneration, 10% of the cases had 
 lordosis were observed  in 
.    85% of  IP patients  cases had bony degeneration, 5
DS and  10% cases had altered  of lordosis were observed  
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24) GRADATION OF RESULTS 
Table 24 : Gradation of Results 
S.No Gradation of Result    
1. Good response 
2. Moderately response
3. Mild  response 
 
 
Figure 24 : Gradation of Results distribution
Inference :  
 80% of cases had   good response, 15% of  cases had moderate
5% of cases had mild response in OP
  75% of cases had good response and 20% of 
5% of cases had mild response in IP.
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distribution 
 
Out Patients (OP) Inpatients (IP)
No of cases % 
No of 
cases 
16 80 15 
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4.3.BIO STATISTICAL ANALYSIS  
Evaluation of Pain score in Out patients 
Descriptive Statistics 
 Mean 
Std. 
Deviation 
N 
Pain score OPB 33.5500 5.05210 20 
Pain score OPA 4.0000 1.83533 20 
 
Correlations 
 Pain score OPB Pain score OPA 
Pain score OPB Pearson Correlation 1 .528* 
Sig. (2-tailed)  .017 
Sum of Squares and 
Cross-products 
484.950 93.000 
Covariance 25.524 4.895 
N 20 20 
Pain score OPA Pearson Correlation .528* 1 
Sig. (2-tailed) .017  
Sum of Squares and 
Cross-products 
93.000 64.000 
Covariance 4.895 3.368 
N 20 20 
*. Correlation is significant at the 0.05 level (2-tailed). 
 
 Pearson correlation () before and after treatment among in patient is 
0.528.One way analysis is variance ANOVA. P- value followed to be less than 0.0001 
is considered to be extremely statistically significant.  
There is strong  evidence (t= 29.699, P< 0.0001) that the clinical trial drug 
importance the Ceganavatham patients. In this date set we could get a mean paired 
difference, df =19, with the confidence interval of 95% the null hypothesis is rejected, 
since P<0.0001. The relation is positive which means that as one variable goes up or 
down so will the other one. 
The two tailed p value is  less than 0.0001 
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Evaluation of Pain score in In patients 
Descriptive Statistics 
 
 
Correlations 
 Pain score BIP Pain score AIP 
Pain score BIP Pearson Correlation 1 .593** 
Sig. (2-tailed)  .006 
Sum of Squares and 
Cross-products 
304.238 57.700 
Covariance 16.013 3.037 
N 20 20 
Pain score AIP Pearson Correlation .593** 1 
Sig. (2-tailed) .006  
Sum of Squares and 
Cross-products 
57.700 31.150 
Covariance 3.037 1.639 
N 20 20 
**. Correlation is significant at the 0.01 level (2-tailed). 
 
Pearson correlation () before and after treatment among in patient is 0.593. 
One way analysis if variance ANOVA. P value followed to be less than 0.0001 is 
considered to be extremely statistically significant.  
There is strong evidence (t=70.308, P<0.0001) that the clinical trial drug 
improves the patients. Mean paired difference, df = 19 with 95% confidence interval. 
The null hypothesis is rejected, since P< 0.0001 suggesting the relationship is a 
positive.  
The two tailed p value is  less than 0.0001 
 
 
 Mean 
Std. 
Deviation 
N 
Pain score BIP 62.9100 4.00157 20 
Pain score AIP 8.0500 1.28042 20 
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One-Sample Statistics 
 N Mean 
Std. 
Deviation 
Std. Error 
Mean 
Pain score OPB 20 33.5500 5.05210 1.12968 
Pain score OPA 20 4.0000 1.83533 .41039 
Pain score IPB 20 62.9100 4.00157 .89478 
Pain score IPA 20 8.0500 1.28042 .28631 
 
One-Sample Test 
 
Test Value = 0 
t df 
Sig. (2-
tailed) 
Mean 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pain score OPB 29.699 19 .000 33.55000 31.1855 35.9145 
Pain score OPA 9.747 19 .000 4.00000 3.1410 4.8590 
Pain score IPB 70.308 19 .000 62.91000 61.0372 64.7828 
Pain score IPA 28.116 19 .000 8.05000 7.4507 8.6493 
 
Evaluation of Pain score in Total 40 patients 
Oneway- Anova 
Anova 
 
Sum of 
Squares 
df 
Mean 
Square 
F Sig. 
Pain score B Between Groups 8620.096 1 8620.096 415.064 .000 
Within Groups 789.188 38 20.768   
Total 9409.284 39    
Pain score A Between Groups 164.025 1 164.025 65.507 .000 
Within Groups 95.150 38 2.504   
Total 259.175 39    
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Independent Samples Test 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Levene's 
Test for 
Equality of 
Variances 
t-test for Equality of Means 
F Sig. t df 
Sig. 
(2-
tailed) 
Mean 
Difference 
Std. Error 
Difference 
95% Confidence 
Interval of the 
Difference 
Lower Upper 
Pain score B Equal 
variances 
assumed 
1.124 .296 
-
20.373 
38 .000 -29.36000 1.44111 
-
32.27738 
-
26.44262 
Equal 
variances 
not assumed 
  
-
20.373 
36.107 .000 -29.36000 1.44111 
-
32.28242 
-
26.43758 
Pain score A Equal 
variances 
assumed 
.075 .786 -8.094 38 .000 -4.05000 .50039 -5.06300 -3.03700 
Equal 
variances 
not assumed 
  
-8.094 33.953 .000 -4.05000 .50039 -5.06698 -3.03302 
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OP Cases (Pain score)  
S.No OP. No Before treatment After Treatment 
1.  29933 60% 9% 
2.  36631 76% 9% 
3.  37539 68% 6% 
4.  37586 70% 9% 
5.  38816 76% 10% 
6.  39106 55.5% 6% 
7.  43818 66% 6% 
8.  44873 70% 9% 
9.  45456 62% 9% 
10.  48017 76% 10% 
11.  48386 76% 6% 
12.  50815 70% 10% 
13.  56705 68% 9% 
14.  59216 57.7% 6% 
15.  62476 66% 6% 
16.  62938 84% 22% 
17.  63604 53.3% 4% 
18.  95942 70% 6% 
19.  8211 76% 6% 
20.  13600 74% 9% 
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IP Cases (Pain score)  
S.No IP. No Before treatment After Treatment 
1.  1287 61.2% 8.2% 
2.  1343 63% 7.4% 
3.  1664 64% 8.8% 
4.  1850 56.2% 6.6% 
5.  2016 62% 8.5% 
6.  2351 64% 7.5% 
7.  2983 60% 9.5% 
8.  3190 57.5% 6.2% 
9.  44 65.8% 9.2% 
10.  45 64% 6.5% 
11.  56 64.5% 8.2% 
12.                     153 58.5% 6.5% 
13.  170 62.2% 8.8% 
14.  179 60.5% 6.2% 
15.  190 58.5% 6.5% 
16.  254 70.5% 10% 
17.  271 72% 8.5% 
18.  278 62.5% 9.5% 
19.  280 64.5% 9.8% 
20.  463 66.8% 8.6% 
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LABORATORY INVESTIGATION (OP PATIENTS) 
S.No OP.No 
HAEMATOLOGICAL INVESTIGAION URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT BEFORE TREATMENT AFTER TREATMENT 
TC 
Cell/cu 
Mm 
DC 
ESR 
mm/
hr 
Hb 
gms
% 
TC 
Cell/c
umm 
DC ES
R 
mm
/1hr 
Hb 
gms
% 
Alb
umi
n 
Sug
ar 
Deposit 
epi/puscells 
Alb
umi
n 
Sug
ar 
Deposit 
epi/puscells P % 
L
% 
E 
% 
P
% 
L
% 
E
% 
1 29933 7000 65 35 2 28 14.5 7400 62 36 2 18 11.4 Nill Nill NAD Nill Nill NAD 
2 36631 7500 67 31 2 25 14 9200 62 35 4 18 11.6 Nill Nill NAD Nill Nill NAD 
3 37539 8700 61 30 3 20 11.4 11500 62 35 5 15 11.4 Nill Nill 1-2 Puscels Nill Nill NAD 
4 37586 8100 77 20 3 24 12.4 9400 65 23 9 18 12.6 Nill Nill 1-2 epicells Nill Nill NAD 
5 38816 8500 68 28 4 20 12.2 8800 58 34 3 20 11.6 Nill Nill 2-5 epicells Nill Nill 1-2epicells 
6 39106 9800 62 32 6 15 13.2 9800 62 35 6 18 11.6 Nill Nill NAD Nill Nill NAD 
7 43818 7500 55 33 2 20 12.1 8000 58 34 4 20 11.8 Nill Nill NAD Nill Nill NAD 
8 44873 8700 59 38 6 25 11.5 8600 62 35 4 18 11.5 Nill Nill NAD Nill Nill NAD 
9 45456 9800 58 36 4 30 10.6 9800 60 36 4 18 10.8 Nill Nill 2-5 epicells Nill Nill 1-3 epicells 
10 48017 8100 67 30 3 33 12.8 9400 65 34 1 15 15.4 Nill Nill NAD Nill Nill NAD 
11 48386 8400 60 31 2 30 8.7 8700 63 35 2 14 10.6 Nill Nill 1-2 puscells Nill Nill NAD 
12 50815 7800 55 44 1 34 11.3 8300 62 35 3 18 12.4 Nill Nill NAD Nill Nill NAD 
13 56705 8600 54 37 3 16 11.2 8700 65 33 2 13 11.8 Nill Nill NAD Nill Nill NAD 
14 59216 8300 45 30 5 15 10.8 9100 63 35 3 11 11.4 Nill Nill NAD Nill Nill NAD 
15 62476 9000 48 34 3 16 13.6 9300 61 38 1 18 14.2 Nill Nill 1-2epicells Nill Nill NAD 
16 62938 6700 65 33 2 23 12.2 9000 60 37 3 12 13.4 Nill Nill NAD Nill Nill NAD 
17 63604 8800 45 30 3 15 12 8700 67 31 2 11 13.8 Nill Nill NAD Nill Nill NAD 
18 95942 8400 50 32 5 15 9.8 8800 62 34 4 13 11.4 Nill Nill NAD Nill Nill NAD 
19 8211 8200 52 30 5 17 12.4 8500 63 35 2 19 13.2 Nill Nill NAD Nill Nill NAD 
20 13600 7500 48 33 4 12 14 7800 61 36 3 15 14.8 Nill Nill 1-3 epicells Nill Nill NAD 
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LABORATORY INVESTIGATION (OP PATIENTS) 
S.No . 
 
 
 
OP.No 
BIOCHEMICAL INVESTIGATION 
BEFORE TREATMENT AFTER TREATMENT 
Sugar 
mgs % 
Urea 
mgs% 
Cholesterol 
mgs % 
Bilirubin 
mgs% 
Creatinine 
mgs % 
Sugar 
mgs % 
Urea 
mgs
% 
Cholesterol 
mgs % 
Bilirubin 
mgs% 
Creatinine 
mgs % 
1 29933 105 18 150 0.6 0.4 95 16 180 0.6 0.6 
2 36631 102 19 150 0.7 0.6 101 20 155 0.8 0.4 
3 37539 108 16 195 0.4 0.9 108 19 195 0.6 0.7 
4 37586 120 21 159 0.6 0.3 103 17 159 0.8 0.5 
5 38816 89 18 168 0.5 0.8 89 20 170 0.3 0.6 
6 39106 98 19 180 0.3 0.6 98 17 177 0.5 0.4 
7 43818 129 22 161 0.9 0.4 110 22 160 0.7 0.8 
8 44873 106 28 180 0.4 0.5 108 25 147 0.8 0.7 
9 45456 107 19 150 0.5 0.7 98 19 168 0.3 0.4 
10 48017 109 20 130 1.0 0.4 107 18 135 0.7 0.6 
11 48386 95 18 170 0.7 0.8 103 13 185 0.4 0.5 
12 50815 107 22 157 0.9 0.6 105 19 170 0.7 0.3 
13 56705 98 29 204 0.3 0.9 89 25 190 0.5 0.7 
14 59216 104 23 203 0.4 0.4 108 17 198 0.6 0.6 
15 62476 92 27 197 0.7 0.6 85 23 193 0.5 0.4 
16 62938 105 24 175 0.4 0.9 109 21 170 0.7 0.7 
17 63604 94 17 193 0.9 0.5 98 19 187 0.6 0.7 
18 95942 103 27 189 0.3 0.7 108 24 178 0.5 0.5 
19 8211 108 31 180 0.5 0.8 102 27 168 0.7 0.3 
20 13600 109 22 179 0.7 0.4 105 17 172 0.5 0.6 
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LABORATORY INVESTIGATION (IP PATIENTS) 
S. 
No. IP No 
HAEMATOLOGICAL INVESTIGAION URINE ANALYSIS 
BEFORE TREATMENT AFTER TREATMENT BEFORE TREATMENT AFTER TREATMENT 
TC 
Cell/ 
cumm 
DC ESR 
mm/
hr 
Hb 
gms
% 
TC 
Cell/ 
cumm 
DC ESR 
mm/ 
hr 
Hb 
gms% 
Alb
umi
n 
Sug
ar 
Deposit 
epi/puscells 
Albu
min 
Suga
r 
Deposit 
epi/ 
puscells 
P 
% 
L
% 
E 
% 
P
% 
L
% 
E
% 
1 1287 8500 61 28 3 24 11.2 8400 68 32 2 20 11.4 Nill Nill NAD Nill Nill NAD 
2 1343 6800 56 33 5 20 10.5 9000 58 40 3 16 10.8 Nill Nill NAD Nill Nill NAD 
3 1664 8700 60 35 5 12 9.4 9200 62 34 4 11 10.8 Nill Nill NAD Nill Nill NAD 
4 1850 7800 65 32 3 16 10.8 8400 64 33 3 13 11.4 Nill Nill 1-3 epicells Nill Nill NAD 
5 2016 7600 60 36 4 20 10 8200 62 37 1 18 11.8 Nill Nill NAD Nill Nill NAD 
6 2351 8500 66 32 2 12 11.8 8700 65 32 3 8 11.4 Nill Nill NAD Nill Nill NAD 
7 2983 7100 67 31 2 18 10.2 8100 65 32 3 14 11.6 Nill Nill 1-2 puscells Nill Nill NAD 
8 3190 9000 61 38 1 15 10.8 9200 65 34 1 12 12.4 Nill Nill NAD Nill Nill NAD 
9 44 8100 72 35 4 12 10.2 8400 63 35 2 10 11.8 Nill Nill NAD Nill Nill NAD 
10 45 7800 63 37 3 8 11 8200 65 37 1 12 12.2 Nill Nill NAD Nill Nill NAD 
11 56 8400 65 33 2 18 10.5 8600 63 35 2 15 11.2 Nill Nill NAD Nill Nill NAD 
12 153 8300 64 32 4 13 11 8900 62 36 2 17 11.6 Nill Nill NAD Nill Nill NAD 
13 170 7500 64 33 3 10 10.4 8100 64 35 1 12 11.2 Nill Nill NAD Nill Nill NAD 
14 179 11500 70 31 2 15 11.2 11200 67 32 2 13 11.8 Nill Nill 1-2 epicells Nill Nill NAD 
15 190 6500 60 39 1 19 10.8 7800 70 30 0 12 11.9 Nill Nill NAD Nill Nill NAD 
16 254 8800 64 31 5 20 10.8 8900 64 33 3 18 11.4 Nill Nill NAD Nill Nill NAD 
17 271 9600 68 30 2 13 11.8 8400 64 32 4 12 11.2 Nill Nill NAD Nill Nill NAD 
18 278 8500 68 31 1 12 10.2 8000 65 33 2 13 13.8 Nill Nill NAD Nill Nill NAD 
19 280 8700 62 34 4 18 9.8 8800 64 33 3 19 10.6 Nill Nill 1-2epicells Nill Nill NAD 
20 463 7100 68 29 3 20 10.5 7500 65 33 2 17 10.8 Nill Nill NAD Nill Nill NAD 
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LABORATORY INVESTIGATION (IP PATIENTS) 
S. No. IP.No 
BIOCHEMICAL INVVESTIGATION 
BEFORE TREATMENT AFTER TREATMENT 
Sugar 
mgs % 
Urea 
mgs% 
Cholesterol 
mgs % 
Bilirubin 
mgs% 
Creatinine 
mgs % 
Sugar 
mgs % 
Urea 
mgs% 
Cholesterol 
mgs % 
Bilirubin 
mgs% 
Creatinine 
mgs % 
1 1287 93 21 165 0.3 0.7 98 19 140 0.5 0.8 
2 1343 104 19 170 0.7 0.8 109 20 170 0.9 0.6 
3 1664 101 25 140 0.5 0.4 107 21 135 0.7 0.4 
4 1850 79 15 250 0.6 0.6 93 18 230 0.8 0.5 
5 2016 80 23 145 0.5 0.8 84 12 150 0.3 0.6 
6 2351 102 21 188 0.7 1.0 108 30 222 0.5 0.8 
7 2983 105 27 227 0.9 0.7 97 23 207 0.7 0.5 
8 3190 107 14 186 0.3 0.9 105 12 180 0.6 0.7 
9 44 95 19 202 0.4 0.4 103 19 197 0.8 0.4 
10 45 107 23 197 0.5 0.6 106 20 212 0.9 0.6 
11 56 105 17 124 0.5 0.5 95 17 138 1.0 0.9 
12 153 98 25 176 0.3 0.7 103 27 147 0.5 0.7 
13 170 109 15 192 0.5 0.3 104 13 205 0.7 0.5 
14 179 107 24 129 0.5 0.8 98 2s2 148 0.6 0.8 
15 190 103 15 125 0.4 0.5 103 21 117 0.5 0.6 
16 254 105 29 203 0.4 0.9 102 25 186 0.4 0.7 
17 271 87 22 138 0.5 0.8 69 19 110 0.3 0.6 
18 278 85 14 218 0.5 0.8 105 17 215 0.6 0.9 
19 280 101 35 180 0.6 1.0 92 30 196 0.8 0.8 
20 463 103 25 126 0.6 0.8 97 22 148 0.9 0.4 
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CASE REPORT OP 20 PATIENTS TREATED FOR CEGANAVATHAM 
S. 
No. OP NO Name Age Sex Occupation 
Duration 
Of Illness 
Date Of 
Admission Treatment with drug/dose 
Date Of 
Discharge 
Total 
Number 
Of Days 
Treated 
Radiological 
Findings Result 
1 29933 Chellammal   52 F Tailor 3 yrs 30.03.2018  
 
 
 
All are treated with 
internally  
AppalakaraChooranam2gm 
twice a day with  water 
29.04.2018 30 days  
 
 
 
 
 
 
 
Cervical 
spondylosis 
Good 
2 36631 Kanthashamy 42 M Loadman 4 yrs 23.04.2018 23.05.2018 30 days Good 
3  37539 Gobikirishna 44 M Driver 6 months 25.04.2018 25.05.2018 30 days Good 
4 37586 Kaneshan 42 M Farmer 2 yrs 26.04.2018 26.05.2018 30 days Good 
5 38816 Thangaraj 55 M Auto driver 1 months 30.04.2018 30.05.2018 30 days Good 
6 39106 Malliga 54 F House wife 1yrs 02.06.2018 O2.07.2018 30 days Good 
7 43818 Karthika 41 F Clerk 2yrs 18.06.2018 18.07.2018 30 days Good 
8 44873 Rathnavel 59 M Peedi worker 6 months 22.06.2018 22.07.2018 30 days Good 
9 45456 Annameri 58 F Housewife 1 yr 25.06.2018 25.07.2018 30 days Good 
10 48017 Ravi 30 M Driver 2  yrs 04.07.2018 03.08.2018 30 days Fair 
11 48386 Megala 57 F Clerk 3 months 05.07.2018 04.08.2018 30 days Fair 
12 50815 Sivaneshan 53 M Peedi worker 2 yrs 15..07.2018 14.08.2018 30 days Good 
13 56705 Sivaneshan 54 M Office Assistant 2 months 06.07.2018 05.08.2018 30 days Good 
14 59216 Abiramavalli 57 F House wife 6 months 16.07.2018 15.08.2018 30 days Good 
15 62476 Balu 58 M Farmer 2 months 27.07.2018 26.08.2018 30 days Good 
16 62938 Vishnukumar 30 M Clerk 1 months 29.07.2018 28.08.2018 30 days Good 
17 63604 Makarani 45 F Housewife 3 months 30.08.2018 30.09.2018 30 days Good 
18 95942 Rajaludsumy 60 F Hotel worker 1 year 20.11.2018 20.12.2018 30 days Good 
19 8211 Janshan 52 M Auto driver 3months 22.01.2019 21.02.2019 30 days Fair 
20 13600 Selva 48 M Tailor 2 months 06.02.2019 06.03.2019 30 days Good 
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CASE REPORT IP 20 PATIENTS TREATED FOR CEGANAVATHAM 
S. 
No. 
IP 
NO. Name Age Sex Occupation 
Duration 
Of Illness 
Date Of 
Admission 
Treatment with 
drug/dose 
Date Of 
Discharge 
Total 
Number 
Of Days 
Treated 
Radiological 
Findings Result 
1 1287 Ananthy 36 M Cottonmills 2 months 14.05.2018  
 
 
 
 
All are treated with 
internally 
AppalakaraChooranam 
2 gm twice a day with  
water 
13.06.2018 30 days  
 
 
 
 
 
 
 
 
Cervical 
spondylosis 
Fair 
2 1343 Vanaraj 43 M Driver 2 months 21.05.2018 20.06.2018 30 days Good 
3 1664 Kuruvammal 50 F Housewife 2 years 27.05.2018 26.06.2018 30 days Fair 
4 1850 Sankarapandiyan 60 M         Farmer 6 months 21.07.2018 20.08.2018 30 days Good 
5 2016 Sanmukanathan 52 M Cotton mills 2 months 06.08.2018 06.09.2018 30 days Good 
6 2351 Nakarani 43 F Teacher 1 year 17.09.2018 17.09.2018 30 days Good 
7 2983 Magaswary 60 F Housewife 6 months 07.12.2018 06.01.2019 30 days Good 
8 3190 Ramasamy 46 M Peediworker 6months 29.12.2018 28.01.2019 30 days Good 
9 44 Samuththirakani 60 F Housewife 3 months 09.01.2019 08.02.2019 30 days Good 
10 45 Vadivu 60 M Maison 3months 09.01.2019 08.02.2019 30 days Good 
11 56 Suppuluxmi 60 F Housewife 3 months 14.01.2019 13.02.2019 30 days Good 
12 153 Ponmani 42 M Hotelservant 1 year 24.01.2019 23.02.2019 30 days Fair 
13 170 Mani 52 M Hotelservant 6 months 26.01.2019 25.02.2019 30 days Good 
14 179 Maddinjude 56 M Farmer 6 months 28.01.2019 27.02.2019 30 days Good 
15 190 Kalpathulla 54 M Farmer 1 year 30.01.2019 29.02.2019 30 days Good 
16 254 Jeyakumar 60 M Tailor 3 months 05.02.2019 07.03.2019 30 days Good 
17 271 Vaithilinkaraja 58   M Driver 3 yers 05.02.2019 07.03.2019 30 days Good 
18 278 Mathuraiveeran 55 M Peedi worker 1year 06.02.2019 08.03.2019 30 days Fair 
19 280 Selvaladsumanan 31 M Clerk 2 months 07.02.2019 09.03.2019 30 days Good 
20 463 Josepkanmani 60 M Farmer 3 weeks 23.02.2019 25.03.2019 30 days Fair 
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CHAPTER V 
DISCUSSION 
Importance of health and healthy life secures absolute attention of humanity 
advancement in the modern technology has enabled our present day society to exist in 
a world where the consent of hard work even moderate physical work is absolute and 
infashionable.The physical inactivity ,the sedentary life, food habits and 
environmental pollution causes by the diseases .The CEGANA VATHAM” is a 
clinical condition, which  was  mentioned in “YUGI VAITHYA CHINTHAMANI  
800 ”.  Cegana vatham is one among the degenerative diseases in vatha disease.The 
clinical symptoms of ceganavatham is   correlated in modern medicine as cervical 
spondylosis. The main clinical features of cegana vatham are painful neck, pain 
radiating to the upper limbs, giddiness, and tingling sensation over the upper limbs. 
Twenty  IP and  twenty OP cases were selected after excluding criteria. Siddha and  
Modern  investigations  was used to  confirm the diagnosis and treatment 
(APPALAKARA CHOORANAM) . 
 
CLINICAL TRIAL OF APPALAKARA CHOORANAM   
01. Incidence with Sex distribution: 
The male ratio was higher than the  female patients, 60% was male patients in 
OP  and  65% patients was in IP.    
 
02. Incidence with Age Distribution: 
This study showed, statistically significant in higher  incidence of 
ceganavatham 60% was affected in,  above 40- 50 years  in OP  and  65%   IP patients  
were affected in  the age group of 51-60 years. Commonly this age is considered in 
degenerative bony changes occurred in cervical spondylosis.    
 
03. Incidence with Kaalam: 
Most of the patients were affected  in Pitha kalam. In  OP  90% and  IP 95% of 
patients were affected   in pitha kaalam. 
 
04. Incidence with reference to Thega nilai: 
Mostly   Vatha piththa thegam  was affected  in cervical spondylosis.  
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05. Incidence with reference to Gunam : 
 The  55%  in OP and 60% in IP patients affected wee with Rajogunam, who 
are more prone to psychological and physical stress. 
 
06. Incidence  reference to  religion: 
The more  incidence was  in Hindus  95% in OP and 90% in IP out of 40 
patients. 
 
07. Incidence with  Thinai: 
 The  highest prevalence in Neithal Nilam. The Siddha literatures mentioned  
that Neithal land is more incidence in Vatha disease.  The 80% in OP and 70% in IP 
patients were affected. Most of the patients were coming from Thoothukkudi and 
Thiruchendur. 
 
08. Distribution according to Paruva Kaalam  
Most of the patients came during  Kaar  kaalam period. 45% in OP and 55% in 
IP patients were affected in Ceganavatham . 
 
09. Incidence with reference  to occupation: 
Occupation of most of the patients strained themselves such as hard worker , 
weight lifter and tailors.This may be the reason for developed  Cegana vatham.  
 
10. Incidence with reference to  Diet: 
Most of the patients belong to non vegetarian.  75% in OP and 70% in IP 
patients were affected in non vegetarian. 
 
11. Incidence with reference to Socio Economic Status: 
70% of  patients in OP and 85% of patients in IP patients were  reported the 
signs and symptoms of Ceganavatham. The middle and lower class peoples  were 
affected in ceganavatham. 
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12. Incidence with reference to etiological factor:  
  Age and  occupation  were the main precipitating factor in majority of the 
cases. 
 
13. Incidence with  reference to mode of onset: 
All the patient were affected  in chronic state. 
 
14. Incidence with duration of illness: 
 Duration of illness in majority of cases were affected more than a year. 
 
15. Incidence with Clinical Manifestations: 
Neck pain  and  radiating pain  towards  upper limbs were  presented  in all  
cases (100%).  
 
16. Incidence with reference to Gnanendrium: 
Mei was affected in all cases.( 100% in both OP&IP). 
 
17. Incidence with reference to Kanmendrium: 
 Kai was affected  in 100% of both OP& IP cases. 
 
18. Conditions of Mukkuttram: 
a.  Disturbance in Vatham: Viyanan and  Samanan were affected in all 40 
cases (100%).The derangements of Viyanan produce pain and restricted neck 
movements .Devathathan was affected in 65%  of  OP  and  35%  in IP patients. It 
produces laziness due to pain.Abanan was affected in 20% of OP and 25% of IP 
patients.It affects bowel movements and produce constipation. 
 
b. Disturbances in Pitham: Sathaga pitham was affected in all 40 cases 
(100%)  which produce difficulty in performing daily regular activities. Analapitham 
was affected in 25% of OP and 15% of IP patients.Ranjagam was affected in 40% of 
OP and 60% of IP patients were affected in Cegana vatham. 
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c. Disturbance in Kapham: Santhigam was affected in all 40 cases (100%), 
which produced restricted neck movements. 
 
19. Incidence with reference  to Udalthathugal: 
The Saram and Enbu were affected in 100% of both OP & IP cases. 
Disturbance of Saram produces symptoms like lethargy and mental depression, where 
as the derangement of kozhuppu and Enbu produced  restricted neck movements and 
osteophytic changes in the  cervical vertebrae.Disturbance in Senner was associated 
with anemia.Enbu affected in 100% of OP and IP patients.Oon affected in 30% of OP 
and 80% of IP patients.Senner was affected in 40% of OP and  60 % of IP patients. 
 
20. Incidence with reference to Envagai Thervugal: 
 The analysis showed, the efficacy of this method and the prime importance of 
naadi. In the study all the OP and IP cases showed thontha nadi in which Vatha  
pitham naadi was predominant.Sparisam was affected in  50% of OP cases and 60% 
of IP cases. Sparisam was affected which was response for pain.  
 
21. Incidence with reference to Neikuri: 
 In neikuri, the  majority of cases were Vatha pitha neer &Vatha kapha neer. 
 
22. Incidence with reference to assessment to  outcome  : 
 After treatment   80%  of   OP   &  75%  of   IP  cases relieved the  good pain 
relief and 20% & 25% of  OP and  IP  cases had  reduced mild and moderate  pain. It 
was confirmed by pain score.  
  
23. Incidence with reference to Radiological studies: 
 X-ray cervical spine (AP& Lateral view) showed 80% -85%  cases had  
degenerative changes occurred  in OP and IP.  
 
24. Incidence  with  reference to result: 
 80% &75% pain was  reduced in  OP and IP cases.20-25% cases had mild to 
moderate effect after  administration of applakara chorrnam.    
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Modern Aspect  investigation  : 
No significant changes were observed before and after the treatment. 
 
Treatment:  
The  APPALAKA  CHOORANAM (internal) – 2 gm, twice  a day with  water 
after food  for 30days.  During treatment all the  patients were advised  pathiyam 
(avoid tamarind, tubers and avoid pillows ). The end of result showed  very good 
clinical improvement (Reduced  neck pain and  improved  neck movements). 
 
Pain Reduction: 
Pain  scale  measurement  NECK DISABILITY INDEX  revealed, the 
significant  reduction in pain and increased  range of motion.The   pain  score was 
reduced in 60-80%  after  administration of the applakara choornam.  
 
Bio Statistical analysis 
 In Out Patient showed the marked changed in standard deviation, mean value 
is 5.05210 to 1.83533 and 33.5500 to 4.000 respectively. Pain score was reduced in 
Pearson correlation an sig.(2 tailed) test showed a significant reduced the score level 
is 0.017. 
 
In In Patient mean and standard deviation was reduced from 62.9100 to 8.0500 
and 4.00157 to 1.28042 respectively. The before and after Pearson correlation and 
sig.(2 tailed) results showed are to less than 0.0001. So, for Bio statistical the 
Appalakaram chooranam was significants reduced the pain.  
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CHAPTER VI 
SUMMARY 
20 cases  in  Ceganavatham were diagnosed clinically  and admitted in 
Inpatients ward and treated with trial medicine. The  20 cases were treated as out 
patients  in post graduate department of Pothu Maruthuvam, Government Siddha 
Medical College &Hospital, palayamkottai .  
 
 The clinical diagnosis was done on the basis of clinical features as  described 
in” Yugi Vaithya Chinthamani-800”. 
 
 The  Appalakara chooranam two gm twice daily  along  with  water was 
given in all selected patients. 
 
 The aetiology, pathology , clinical features, classification, and prognosis of the 
Cegana vatham were collected  from  the  various  literatures  in siddha as 
well as modern  medicine. 
 
 Before starting the treatment careful detailed history was  recorded in all  
selected cases. 
 
 Laboratory diagnosis of Ceganavatham was done by Siddha and modern  
diagnostic  methods of investigations. 
 
 The trial medicine  was corrected in  deranged  uyirthathukkal and 
udalthathukkal.So, the patients were relieved from the symptoms  of  neck 
pain, stiffness, radiating pain to the upper limbs. This   confirms the efficacy 
of the trial medicine in curing the disease . 
 
  The  end results were found to be good relief from the symptoms within 
10days of treatment in mild case. In moderate cases good relief was found 
between15-20 days of treatment. In severe cases mild improvement found 
after 30 days of treatment. 
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 During the period of treatment all the patients were put under pathiyam (A 
specific dietary regimen) 
 
 The relief or improvement was  observed only clinically and there was no 
changes in radiological findings. 
 
 As per literary evidence  Siddha Gunapadam Thathu Jeeva Vagupu,    
mentionend,  of the trial medicine were  controlling vatha disease. 
 
 No toxic effects were noticed during the treatment period and pre clinical 
analysis of the Appalakara chooranam.All the drugs were put to use only after 
careful purification process laid down for them individually. 
 
 The observations made during the clinical study showed   Appalakara 
chooranam is  clinically effective. 
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CHAPTER VII 
CONCLUSION 
 In this study, the treatment of cegana vatham with Appalakara chooranam  
was a  good relief for the pain in ceganavatham. 
 
 The relief (or) improvement was observed  clinically by using pain score and  
movements of neck . 
 
 The trial medicine has proved a significant action of Analgesic and Anti 
inflamatory activity, was confirmed by  pharmacological studies. 
 
 The presence of Carbonate, Chloride,Ferrous iron, sulphate and unsaturated 
compounds were found in Bio-chemical analysis.   
 
 No toxic effects were noticed during the treatment period. It was confirmed 
by In Vitro – In Vivo, acute and sub-acute toxic studies. 
 
 Bio statistically proved the Appalakara chooranam was significant reduced   
the  pain and neck stability. (P<0.0001)  
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     ANNEXURE -I 
                           PREPRATION OF THE TRIAL DRUGS 
             DRUGS  NAME :    APPALAKARA  CHOORANAM 
Purification and Preparation of  Appalakara Chooranam 
The Appalakaram collected and washed with water then added with water and 
boild      finaly dry in  sunlight.  Purified Appala karam is grinded into  powder  in the 
Kalvam.                                                                                                                                                     
Ingredients of  Appalakara Chooranam 
TAMIL 
NAME 
CHEMICAL  
NAME 
CHEMICAL 
COMPOSITION ACTIONS 
THERAPEUTIC 
USES IN SIDDHA 
 Appala
karam 
 Sodium 
Carbonate or 
Subcarbonate 
of soda  
Na2 CO3 Annti 
inflammation, 
Annalgesic 
Antiulcer 
Vatha Disease 
Gunmam. 
 
Dosage : 30mg/ Kg/BW/daily two times a day 
Adjuvant :   water 
Duration : 30 days 
Reference : GunapadamThathu Jeevavaguppu Part II& III, Page No.368 
                                                    
 
 
 
 
 
 
 
 
 
 
 
 
                                                     
 
 
 
ANNEXURE II 
NECK DISABILITY INDEX SCORE 
• This questionnaire has been designed to give us information as 
to how your neck pain has affected your ability to manage in 
everyday life. Please answer ever section and mark in each section 
only the one box that applies to you 
 
 
Section 1:-  
Pain Intensity SCORE PATIENT’S SCORE 
• I have no pain at the moment  0  
• The Pain is very mild at the moment  1 
• The Pain is moderate at the moment  2 
• The Pain is fairly severe at the 
moment  
3 
• The Pain is very severe at the moment  4 
• The Pain is the worst imaginable at the 
moment  
5 
 
Section 2:-  
PERSONAL CARE (WASHING, DRESSING, 
etc) 
SCORE PATIENT’S SCORE 
• I Can look after myself normally without 
causing extra pain  
0  
• I Can look after myself normally but it 
causes extra pain  
1 
• It is Painful to look after myself and I am 
slow and careful  
2 
• I need some help but can manage most of 
my personal care 
3 
• I need help everyday in most aspects of self 
care 
4 
• I do not get dressed, I wash with difficulty 
and stay in bed 
5 
Section 3:-  
LIFTING  SCORE PATIENT’S SCORE 
• I Can lift heavy weights without extra pain  0  
• I Can lift heavy weights but it gives extra 
pain 
1 
• Pain Prevents me lifting heavy weights off 
the floor, but I can manage if they are 
conveniently Placed, for example on a 
table  
2 
• Pain Prevents me from lifting heavy 
weights but I can manage light to medium 
weights if they care conveniently 
positioned  
3 
• I Can only lift very light weights 4 
• I cannot lift or carry anything  5 
 
Section 4:-  
READING  SCORE PATIENT’S SCORE 
• I Can read as much as I want to with no 
pain in My neck  
0  
• I can read as much as I want to with slight 
pain in my neck  
1 
• I can read as much as I want with 
moderate pain in my neck  
2 
• I Can’t read as much as I want because of 
moderate  pain in my neck  
3 
• I Can hardly read at all because of severe 
pain in my neck  
4 
• I cannot read at all  5 
 
 
 
 
Section 5:-  
HEADACHES  SCORE PATIENT’S SCORE 
• I have no headaches at all  0  
• I have slight headaches, which come 
infrequently  
1 
• I have moderate headaches, which come 
infrequently  
2 
• I have moderate headaches, which come 
frequently  
3 
• I have severe headaches, which come 
frequently  
4 
• I have headaches almost all the time  5 
 
Section 6:-  
CONCENTRATION  SCORE PATIENT’S SCORE 
• I Can Concentrate fully when I want to 
with no difficulty 
0  
• I can concentrate fully when I want to with 
slight difficulty  
1 
• I have a fair degree of difficulty in 
concentrating when I want to  
2 
• I have a lot of difficulty in concentrating 
when I want to  
3 
• I have a great deal of difficulty in 
concentrating when I want to  
4 
• I Cannot concentrate at all  5 
 
 
 
 
 
 
 
Section 7:-  
WORK SCORE PATIENT’S SCORE 
• I Can do as much work as I want to  0  
• I Can only do my usual work, but no more 1 
• I Can do most of my usual work, but no 
more 
2 
• I cannot do my usual work  3 
• I Can hardly do any work at all  4 
• I Can’t do any work at all  5 
 
Section 8:-  
DRIVING SCORE PATIENT’S SCORE 
• I Can drive my car without any neck pain  0  
• I Can drive my car as long as I want with 
slight pain in my neck  
1 
• I Can drive my car as long as I want with 
moderate pain in my neck  
2 
• I Can’t drive my car as long as I want 
because of moderate pain in my neck  
3 
• I Can hardly drive at all because of severe 
pain in my neck  
4 
• I Can’t drive my car at all  5 
 
Section 9:-  
SLEEPING SCORE PATIENT’S SCORE 
• I have no trouble sleeping  0  
• My Sleep is slightly disturbed (less than 
1hr sleepless)  
1 
• My Sleep is mildly disturbed (1-2 hrs 
sleepless)  
2 
• My Sleep is moderately disturbed ( 2-3 hrs 
Sleepless)  
3 
• My Sleep is greatly disturbed (3-5 hrs 
sleepless)  
4  
• My Sleep is completely disturbed (5-7 hrs 
sleepless) 
5 
 
Section 10:-  
RECREATION  SCORE PATIENT’S SCORE 
• I am able to engage in all my recreation 
activities with no neck pain at all  
0  
• I am able to engage in all my recreation 
activities, with some pain in my neck  
1 
• I am able to engage in most, but not all of 
my usual recreation activities because of 
pain is my neck  
2 
• I am able to engage in a few of my usual 
recreation activities because of pain in my 
neck  
3 
• I Can hardly do any recreation activities 
because of pain in my neck  
4 
• I Can’t do any recreation activities at all  5 
 
 
Neck disability Index Score  
 
Score: /50 Transform to percentage score x 100 = % points 
• Scoring: For each section the total possible score is 5: If the first statement is 
marked the section score = 0, if the last statement is marked it = 5.  
• If all ten Sections are completed the score is calculated as follows: Example: 
16 (total Scored) 50 (Total Possible Score) x 100 = 32% 
• If one section is missed or not applicable the score is calculated: 16 (total 
Scored) 45 (total Possible Score) x 100 = 35.5% 
• Minimum Detectable change (90% Confidence):  
5 Points or 10% Points 
NDI developed by: Vernon, H.& Mior, 
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